# FewerJobs export - 100 curated jobs Generated: 2026-10-01T23:39:06.453Z Source: https://fewerjobs.com ## Filters applied - **q**: Mirum Pharmaceuticals Inc - **quality_floor**: default - **match_401k_strict**: true - **parental_strict**: true - **non_birth_strict**: true - **pto_strict**: true - **include_older**: false - **apply_url_verified**: false - **page**: 2 - **per_page**: 100 - **sort**: relevance ## Jobs ### VP, Clinical Development - Infectious Disease - Tonix Pharmaceuticals Holding Corp - Location: Frederick, Maryland or Berkeley Heights, New Jersey (unspecified) - Salary: $250K-$350K - Posted: 2026-01-20 - 401(k) match: listed (not source-backed) - Apply: https://job-boards.greenhouse.io/tonixpharmaceuticals/jobs/4108447009 - Excerpt: VP, Clinical Development - Infectious Disease Frederick, Maryland or Berkeley Heights, New Jersey Tonix Pharmaceuticals* is a fully integrated, commercial-stage biotechnology company focused on central nervous system (CNS) and immunology treatments in areas of high unmet medical need. TONMYA® (cyclobenzaprine HCl sublingual tablets 2.8 mg) is the first new treatment for fibromyalgia in adults in more than 15 years. Tonix's CNS commercial infrastructure supports its marketed products, including its acute migraine products, Zembrace® Symtouch® (sumatriptan injection 3 mg) and Tosymra® (sumatriptan nasal spray 10 mg). Tonix is investigating TONMYA® in Phase 2 clinical trials to evaluate its potential in major depressive disorder and acute stress disorder/acute stress reaction. Tonix is also advancing a pipeline of immunology programs, including TNX-4800, a Phase 2 ready long-acting human anti- Borrelia OspA monoclonal antibody (mAb) for the prevention of Lyme disease in the U.S., and TNX-1500, a Phase 2 ready third-generation CD40 ligand inhibitor for the prevention of kidney transplant rejection. In addition, the Company is progressing TNX-2900 (intranasal potentiated oxytocin), which is Phase 2 ready for the treatment of Prader-Willi syndrome, a rare disease. To learn more, visit www.tonixpharma.com and follow the Company on LinkedIn and X . *Tonix's product development candidates are investigational new drugs or biologics; their efficacy and safety have not been established and have not been approved for any indication. Zembrace SymTouch and Tosymra are registered trademarks of Tonix Medicines. TONMYA is a registered trademark of Tonix Pharma Limited. All other marks are property of their respective owners. Position ### Technician, Pharmaceutical - AbbVie Inc. - Location: Sligo, SO, Ireland (unspecified) - Salary: Not disclosed - Posted: 2026-06-12 - Parental leave: 12 weeks (not source-backed) - Non-birth-parent leave: 12 weeks (not source-backed) - 401(k) match: listed (not source-backed) - Apply: https://jobs.smartrecruiters.com/AbbVie/3743990013577016-technician-pharmaceutical - Excerpt: Technician, Pharmaceutical Sligo, SO, Ireland Company Description: About AbbVie AbbVie's mission is to discover and deliver innovative medicines and solutions that solve serious health issues today and address the medical challenges of tomorrow. We strive to have a remarkable impact on people's lives across several key therapeutic areas including immunology, oncology and neuroscience - and products and services in our Allergan Aesthetics portfolio. For more information about AbbVie, please visit us at www.abbvie.com . Follow @abbvie on LinkedIn, Facebook , Instagram , X and YouTube. Job Description: We are recruiting a Pharmaceutical Technician to join our team on site in Manorhamilton Road, Sligo on a 12 month fixed-term contract. This role is rotational shift work. In your role as Pharmaceutical Technician you will be responsible for producing drug product materials as per organizational needs in line with all relevant compliance requirements. This person will operate as a team member in a pharmaceutical processing facility in line with all regulatory and organizational requirements. A snapshot of your key responsibilities as a Pharmaceutical Technician would be: Pharmaceutical processing activities in our manufacturing building and support locations. Team co-ordination to maximise the effectiveness of the team members. Documentation of all activities in line with cGMP requirements. Cross training within the team and training of new team members. Participation in continuous improvement programs to implement improvements in the quality, safety, environmental and production systems. Execution of commissioning and validation protocols on an ongoing basis. Maintaining the overall cGMP of the pharmaceutical processing areas. Adheres ### Director, Medical Science Liaison (OH, W. Virginia, W. PA, Upstate NY) - Revolution Medicines - Location: Remote (United States) (remote) - Salary: $236K-$259K - Posted: 2026-05-14 - 401(k) match: listed (not source-backed) - Apply: https://www.revmed.com/careers-list/?gh_jid=7734093003 - Excerpt: Director, Medical Science Liaison (OH, W. Virginia, W. PA, Upstate NY) Remote (United States) Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company's R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company's RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. As a new member of the Revolution Medicines team, you will join other outstanding professionals in a tireless commitment to patients with cancers harboring mutations in the RAS signaling pathway. The Opportunity: We are seeking a highly motivated and experienced professional to join our team as a Lung Medical Science Liaison. Key aspects of this role will include engage in peer-to-peer scientific dialogue with healthcare professionals that translate into meaningful insights, serve as a therapeutic expert and thought partner to internal teams, liaison between Revolution Medicines and clinical study sites / investigators, and provide support for medical education, advisory boards, and medical congresses. Medical Science Liaisons (MSLs) are an essential member of the Medical Affairs team who will work as an extension of the Medical Affairs organization. The Lung MSL team will serve as a key liaison between Revolution Medicines and healthcare professionals. Within an assigned geographic territory, the MSL will be responsible for cultivating and strengthening professional relationships with key opinion leaders (KOLs), healthcare providers, and academic centers of ### Director, Medical Science Liaison (Philadelphia, Hershey, NJ, MD, DC) - Revolution Medicines - Location: Remote (United States) (remote) - Salary: $236K-$259K - Posted: 2026-05-14 - 401(k) match: listed (not source-backed) - Apply: https://www.revmed.com/careers-list/?gh_jid=7734103003 - Excerpt: Director, Medical Science Liaison (Philadelphia, Hershey, NJ, MD, DC) Remote (United States) Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company's R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company's RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. As a new member of the Revolution Medicines team, you will join other outstanding professionals in a tireless commitment to patients with cancers harboring mutations in the RAS signaling pathway. The Opportunity: We are seeking a highly motivated and experienced professional to join our team as a Lung Medical Science Liaison. Key aspects of this role will include engage in peer-to-peer scientific dialogue with healthcare professionals that translate into meaningful insights, serve as a therapeutic expert and thought partner to internal teams, liaison between Revolution Medicines and clinical study sites / investigators, and provide support for medical education, advisory boards, and medical congresses. Medical Science Liaisons (MSLs) are an essential member of the Medical Affairs team who will work as an extension of the Medical Affairs organization. The Lung MSL team will serve as a key liaison between Revolution Medicines and healthcare professionals. Within an assigned geographic territory, the MSL will be responsible for cultivating and strengthening professional relationships with key opinion leaders (KOLs), healthcare providers, and academic centers of excellence involved ### Senior Director of Translational Sciences - Lb Pharmaceuticals Inc - Location: Location not specified (unspecified) - Salary: Not disclosed - Posted: 2026-06-12 - Apply: https://lbpharmaceuticals.bamboohr.com/careers/35 - Excerpt: Senior Director of Translational Sciences Senior Director of Translational Sciences ### Medical Science Liaison - Vaxcyte Inc - Location: US - Remote (remote) - Salary: $184K-$215K - Posted: 2026-04-27 - 401(k) match: listed (not source-backed) - Apply: https://boards.greenhouse.io/vaxcyte/jobs/5195807008?gh_jid=5195807008 - Excerpt: Medical Science Liaison US - Remote Join our Mission to Protect Humankind! Vaxcyte is a clinical-stage vaccine innovation company engineering high-fidelity vaccines to protect humankind from the consequences of bacterial diseases, which have serious and costly health consequences when left unchecked. Working to eradicate or treat bacterial infections such as invasive pneumococcal disease, Group A Strep, and Shigella is just the beginning. Our path to success is clear and well-defined, and Vaxcyte is set up to go the distance. WHAT we do is every bit as important as HOW we do it! Our work together is guided by four enduring core values: *RETHINK CONVENTION: We bring creative and intellectual diversity to every facet of the work we do in order to innovate and re-innovate the way vaccines are delivered. *AIM HIGH: We embody our collectively audacious goal to courageously make the most complex biologics ever attempted to protect humankind. *LEAD WITH HEART: Everyone leads at Vaxcyte with a kindness-first, inclusive approach to collaboration and vigorous debate that advances our business objectives. *MODEL EXCELLENCE: The magnitude of our challenge requires our shared commitment to demonstrating integrity, accountability, equality and clarity across communications and decision making. Summary: We are seeking a scientifically driven and communicative Medical Science Liaison (MSL) to join our Medical Affairs team. The Medical Science Liaison (MSL) serves as a scientific expert in immunization and pneumococcal disease prevention. This field-based role will serve as a trusted scientific partner to healthcare providers, public health officials, and key opinion leaders (KOLs) ### Pharmaceutical Technician - 6 Month Contract - AbbVie Inc. - Location: Sligo, SO, Ireland (unspecified) - Salary: Not disclosed - Posted: 2026-06-10 - Parental leave: 12 weeks (not source-backed) - Non-birth-parent leave: 12 weeks (not source-backed) - 401(k) match: listed (not source-backed) - Apply: https://jobs.smartrecruiters.com/AbbVie/3743990012973717-pharmaceutical-technician-6-month-contract - Excerpt: Pharmaceutical Technician - 6 Month Contract Sligo, SO, Ireland Company Description: About AbbVie AbbVie's mission is to discover and deliver innovative medicines and solutions that solve serious health issues today and address the medical challenges of tomorrow. We strive to have a remarkable impact on people's lives across several key therapeutic areas including immunology, oncology and neuroscience - and products and services in our Allergan Aesthetics portfolio. For more information about AbbVie, please visit us at www.abbvie.com . Follow @abbvie on LinkedIn, Facebook , Instagram , X and YouTube. Job Description: We are recruiting a Pharmaceutical Technician to join our team on site in Manorhamilton Road, Sligo on a 6 month fixed-term contract. This role is rotational shift work. In your role as Pharmaceutical Technician you will be responsible for producing drug product materials as per organizational needs in line with all relevant compliance requirements. This person will operate as a team member in a pharmaceutical processing facility in line with all regulatory and organizational requirements. A snapshot of your key responsibilities as a Pharmaceutical Technician would be: Pharmaceutical processing activities in our manufacturing building and support locations. Team co-ordination to maximise the effectiveness of the team members. Documentation of all activities in line with cGMP requirements. Cross training within the team and training of new team members. Participation in continuous improvement programs to implement improvements in the quality, safety, environmental and production systems. Execution of commissioning and validation protocols on an ongoing basis. Maintaining the overall cGMP of the ### Associate Director, Global Omnichannel Solutions Delivery - Revolution Medicines - Location: Redwood City, California, United States (unspecified) - Salary: $186K-$233K - Posted: 2026-05-22 - 401(k) match: listed (not source-backed) - Apply: https://www.revmed.com/careers-list/?gh_jid=7655280003 - Excerpt: Associate Director, Global Omnichannel Solutions Delivery Redwood City, California, United States Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company's R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company's RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. As a new member of the Revolution Medicines team, you will join other outstanding professionals in a tireless commitment to patients with cancers harboring mutations in the RAS signaling pathway. The Opportunity: RevMed is seeking a strategic and experienced technology leader to join our Information Sciences (IS) team as Associate Director, Global Omnichannel Solutions Delivery. This role will ensure our omnichannel technology ecosystem is connected, scalable, and globally ready, enabling seamless customer experiences across markets outside of the US. The individual will play a critical role in supporting global expansion by establishing scalable solutions, enabling adoption of global platforms, and ensuring new capabilities, brands, and regions can be added efficiently without rework or fragmentation. The ideal candidate brings strong technical acumen, experience working across multiple marketing technologies, and the ability to translate complex business needs into scalable, globally consistent solutions. Key responsibilities: Global Omnichannel Enablement - Lead deployment of integrated customer journeys across ex-US markets, ensuring alignment with global platform strategy. - Enable launch, medical, and global expansion priorities through scalable solution enablement. ### MES Engineer (Night Shift) - Genentech, Inc. - Location: Hillsboro, Oregon, United States of America (unspecified) - Salary: Not disclosed - Posted: 2026-05-20 - 401(k) match: listed (not source-backed) - Apply: https://roche.wd3.myworkdayjobs.com/ROG-A2O-GENE/job/Hillsboro/MES-Engineer--Night-Shift-_202601-102416-1/apply - Excerpt: MES Engineer (Night Shift) Hillsboro, Oregon, United States of America Embrace the role of an MES Engineer (Night Shift) and play a pivotal role in advancing digital manufacturing for a leading pharmaceutical company. Leverage your expertise in MES, GMP, and automation to support critical operations, drive process improvements, and ensure quality in a dynamic, automated environment. Shape the future of pharmaceutical manufacturing with us! ### Senior Manager, Business Analysis and Project Management - Revolution Medicines - Location: Redwood City, California, United States (unspecified) - Salary: $164K-$205K - Posted: 2026-04-14 - 401(k) match: listed (not source-backed) - Apply: https://www.revmed.com/careers-list/?gh_jid=7695694003 - Excerpt: Senior Manager, Business Analysis and Project Management Redwood City, California, United States Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company's R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company's RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. As a new member of the Revolution Medicines team, you will join other outstanding professionals in a tireless commitment to patients with cancers harboring mutations in the RAS signaling pathway. The Opportunity: The Senior Manager, Business Analysis & Project Management is a strategic leadership role within the Information Sciences organization, responsible for driving enterprise technology initiatives that support pharmaceutical research, development, manufacturing, quality, and commercial operations. This role requires creation of business and Sciences requirements leading to delivery of complex, cross-functional projects while maintaining compliance with regulatory and validation requirements. The role partners closely with business and IS leadership to translate business strategies into scalable, compliant technology solutions, while ensuring projects are delivered on time, within scope, and within budget. Key Responsibilities: Strategic Leadership & Governance - Develop and execute the Business Analysis and Project Management strategy aligned with enterprise IS and business objectives. - Establish and enforce standardized methodologies, templates, tools, and best practices (Agile, Waterfall, Hybrid). - Provide portfolio-level oversight, prioritization, and delivery governance for IS initiatives. - Serve as ### Director of Project Management-Clinical - Lb Pharmaceuticals Inc - Location: Location not specified (unspecified) - Salary: Not disclosed - Posted: 2026-06-12 - Apply: https://lbpharmaceuticals.bamboohr.com/careers/37 - Excerpt: Director of Project Management-Clinical Director of Project Management-Clinical ### Senior Financial Analyst/Finance Manager - Revolution Medicines - Location: Redwood City, California, United States (unspecified) - Salary: $120K-$150K - Posted: 2026-04-22 - 401(k) match: listed (not source-backed) - Apply: https://www.revmed.com/careers-list/?gh_jid=7686136003 - Excerpt: Senior Financial Analyst/Finance Manager Redwood City, California, United States Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company's R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company's RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. As a new member of the Revolution Medicines team, you will join other outstanding professionals in a tireless commitment to patients with cancers harboring mutations in the RAS signaling pathway. The Opportunity: Revolution Medicines is seeking a Sr. Financial Analyst/Finance Manager to support our growing needs in Development and R&D Finance. The successful candidate will have experience with clinical trials, R&D accruals process, month-end close, financial reporting, SOX, and audit support. This position is based out of our headquarters in Redwood City, CA. - Reporting to the Associate Director, FP&A and will serve as a business partner to Clinical Operations and cross-functional partner to Accounting, Finance, and Procurement. - Prepare month-end clinical trial accruals, including review of CRO reports, patient costs, and site payments. - Prepare monthly and quarterly reconciliations for accrued clinical and related prepaid accounts. - Contribute to Identify, design, and implement process improvements to streamline clinical trial accruals, reducing manual effort and improving accuracy and timeliness. - Review contracts and amendments to analyze and determine impact on clinical accruals. - Prepare contract ### Vice President, Portfolio and Program Strategy - Lb Pharmaceuticals Inc - Location: Location not specified (unspecified) - Salary: Not disclosed - Posted: 2026-06-12 - Apply: https://lbpharmaceuticals.bamboohr.com/careers/31 - Excerpt: Vice President, Portfolio and Program Strategy Vice President, Portfolio and Program Strategy ### Executive Director, Portfolio Management - Revolution Medicines - Location: Redwood City, California, United States (unspecified) - Salary: $265K-$331K - Posted: 2025-04-24 - 401(k) match: listed (not source-backed) - Apply: https://www.revmed.com/careers-list/?gh_jid=6530477003 - Excerpt: Executive Director, Portfolio Management Redwood City, California, United States Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company's R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company's RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. As a new member of the Revolution Medicines team, you will join other outstanding professionals in a tireless commitment to patients with cancers harboring mutations in the RAS signaling pathway. The Opportunity: We are looking for a highly motivated individual with experience in portfolio management, decision analysis and a passion for developing solutions for complex problems to build out this cross-functional capability and help shape our portfolio strategy. This position will report to the SVP, Development Management and Program Leadership and will be based at our headquarters in Redwood City, CA. In this highly cross functional role, you will be expected to evolve the wider portfolio management capability within Revolution Medicines and closely collaborate with Portfolio Working Group, Disease Area Teams, Program Teams, Life Cycle Teams, Analytics and Insights, Finance, Commercial and many other relevant functions. You must be entrepreneurial, able to “roll up their sleeves” and thrive in a fast-paced, highly cross-functional environment. You are an exceptional strategic and critical thinker, have a passion for interpreting and analyzing complex data, and have strong interpersonal ### Director of Clinical Operations, Phase I Enabling Studies - Lb Pharmaceuticals Inc - Location: Location not specified (unspecified) - Salary: Not disclosed - Posted: 2026-06-12 - Apply: https://lbpharmaceuticals.bamboohr.com/careers/27 - Excerpt: Director of Clinical Operations, Phase I Enabling Studies Director of Clinical Operations, Phase I Enabling Studies ### Associate Director, Business Operations - Revolution Medicines - Location: Redwood City, California, United States (unspecified) - Salary: $186K-$233K - Posted: 2026-05-28 - 401(k) match: listed (not source-backed) - Apply: https://www.revmed.com/careers-list/?gh_jid=7751588003 - Excerpt: Associate Director, Business Operations Redwood City, California, United States Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company's R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company's RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. As a new member of the Revolution Medicines team, you will join other outstanding professionals in a tireless commitment to patients with cancers harboring mutations in the RAS signaling pathway. The Opportunity: The Associate Director, Business Operations is an internal project manager with a consultant mindset and hands-on approach. This is an execution-focused role that strengthens the business capabilities in the Development & Clinical Sciences (DCS) organization. This role partners closely with the Development Leadership Team and the Program Leads to design and implement capabilities building projects that enable growth and evolve our ways of working. The role is ideal for a Associate Director -level professional who thrives on execution, can drive several projects in parallel, can navigate a matrix environment, and brings strong project leadership, communication and change management experience. Responsibilities: - Enablement Programs & Tools - Design and deploy practical solutions (e.g., templates, toolkits, playbooks, workflows) that enable DCS teams in their day-to-day work. - Ensure solutions are practical, scalable, and embedded into existing processes. - Partner with subject-matter experts to translate complex ### Pharmaceutical Technician II - Thermo Fisher Scientific - Location: Singapore, Singapore (unspecified) - Salary: Not disclosed - Posted: 2026-06-11 - 401(k) match: listed (not source-backed) - Apply: https://thermofisher.wd5.myworkdayjobs.com/ThermoFisherCareers/job/Singapore-Singapore/Pharmaceutical-Technician-II_R-01354187/apply - Excerpt: Pharmaceutical Technician II Singapore, Singapore Embrace the role of a Pharmaceutical Technician II and play a vital role in sterile pharmaceutical production. Operate advanced equipment, ensure GMP compliance, and support quality manufacturing processes. If you have hands-on experience in pharmaceutical manufacturing and a passion for safety and precision, this is your opportunity to make an impact. ### Director, Financial Planning & Analysis, R&D - Vaxcyte Inc - Location: San Carlos, California, United States (unspecified) - Salary: $226K-$264K - Posted: 2026-04-03 - 401(k) match: listed (not source-backed) - Apply: https://boards.greenhouse.io/vaxcyte/jobs/5173368008?gh_jid=5173368008 - Excerpt: Director, Financial Planning & Analysis, R&D San Carlos, California, United States Join our Mission to Protect Humankind! Vaxcyte is a clinical-stage vaccine innovation company engineering high-fidelity vaccines to protect humankind from the consequences of bacterial diseases, which have serious and costly health consequences when left unchecked. Working to eradicate or treat bacterial infections such as invasive pneumococcal disease, Group A Strep, and Shigella is just the beginning. Our path to success is clear and well-defined, and Vaxcyte is set up to go the distance. WHAT we do is every bit as important as HOW we do it! Our work together is guided by four enduring core values: *RETHINK CONVENTION: We bring creative and intellectual diversity to every facet of the work we do in order to innovate and re-innovate the way vaccines are delivered. *AIM HIGH: We embody our collectively audacious goal to courageously make the most complex biologics ever attempted to protect humankind. *LEAD WITH HEART: Everyone leads at Vaxcyte with a kindness-first, inclusive approach to collaboration and vigorous debate that advances our business objectives. *MODEL EXCELLENCE: The magnitude of our challenge requires our shared commitment to demonstrating integrity, accountability, equality and clarity across communications and decision making. Summary: This is an exciting opportunity to serve as a strategic finance business partner to Vaxcyte's R&D organization, with a focus on clinical studies. The role will support Clinical Operations and the Immunoassay and Non-Clinical teams, with responsibility for clinical trial and serology financial oversight, while flexing to support broader R&D ### FSP SCRA I（Changsha） - Fortrea Holdings Inc - Location: Shanghai, China (unspecified) - Salary: Not disclosed - Posted: 2024-12-18 - 401(k) match: listed (not source-backed) - Apply: https://fortrea.wd1.myworkdayjobs.com/Fortrea/job/Shanghai/FSP-SCRA-I-Changsha-_2447386/apply - Excerpt: FSP SCRA I（Changsha） Shanghai, China As a leading global contract research organization (CRO) with a passion for scientific rigor and decades of clinical development experience, Fortrea provides pharmaceutical, biotechnology, and med... ### Senior Associate Engineer, Upstream Development for Protein Development and Manufacturing (Contract) - Vaxcyte Inc - Location: San Carlos, California, United States (unspecified) - Salary: $57-$63/hr - Posted: 2026-06-01 - 401(k) match: listed (not source-backed) - Apply: https://boards.greenhouse.io/vaxcyte/jobs/5194792008?gh_jid=5194792008 - Excerpt: Senior Associate Engineer, Upstream Development for Protein Development and Manufacturing (Contract) San Carlos, California, United States Join our Mission to Protect Humankind! Vaxcyte is a clinical-stage vaccine innovation company engineering high-fidelity vaccines to protect humankind from the consequences of bacterial diseases, which have serious and costly health consequences when left unchecked. Working to eradicate or treat bacterial infections such as invasive pneumococcal disease, Group A Strep, and Shigella is just the beginning. Our path to success is clear and well-defined, and Vaxcyte is set up to go the distance. WHAT we do is every bit as important as HOW we do it! Our work together is guided by four enduring core values: *RETHINK CONVENTION: We bring creative and intellectual diversity to every facet of the work we do in order to innovate and re-innovate the way vaccines are delivered. *AIM HIGH: We embody our collectively audacious goal to courageously make the most complex biologics ever attempted to protect humankind. *LEAD WITH HEART: Everyone leads at Vaxcyte with a kindness-first, inclusive approach to collaboration and vigorous debate that advances our business objectives. *MODEL EXCELLENCE: The magnitude of our challenge requires our shared commitment to demonstrating integrity, accountability, equality and clarity across communications and decision making. Summary: Vaxcyte is seeking a talented and experienced Senior Associate Engineer to join the Upstream Process Development group within the Protein Development and CMC team. This is an exciting opportunity to join an outstanding team pursuing bacterial fermentation development at Vaxcyte. The successful candidate will have ### Pharmaceutical Technician II - Thermo Fisher Scientific - Location: Singapore, Singapore (unspecified) - Salary: Not disclosed - Posted: 2026-06-11 - 401(k) match: listed (not source-backed) - Apply: https://thermofisher.wd5.myworkdayjobs.com/ThermoFisherCareers/job/Singapore-Singapore/Pharmaceutical-Technician-II_R-01349946-1/apply - Excerpt: Pharmaceutical Technician II Singapore, Singapore Embrace the role of a Pharmaceutical Technician II and play a vital role in sterile pharmaceutical production. Operate advanced equipment, ensure GMP compliance, and support quality manufacturing processes. Ideal for candidates with 1-5 years' experience in pharma, this role offers hands-on work in a dynamic, safety-focused environment. Grow your career in pharmaceutical manufacturing today! ### Senior Manager, Marketing, Lung - Revolution Medicines - Location: Remote (United States) (remote) - Salary: $150K-$189K - Posted: 2026-06-09 - 401(k) match: listed (not source-backed) - Apply: https://www.revmed.com/careers-list/?gh_jid=7767420003 - Excerpt: Senior Manager, Marketing, Lung Remote (United States) Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company's R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company's RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. As a new member of the Revolution Medicines team, you will join other outstanding professionals in a tireless commitment to patients with cancers harboring mutations in the RAS signaling pathway. The Opportunity: As a Senior Marketing Manager, you will be a key contributor to the development of compelling omnichannel campaigns that promote Revolution Medicine's values, scientific innovation, and patient centricity. You will develop and execute marketing strategies and plans to achieve brand objectives and growth targets, particularly for non-personal promotion initiatives. Identification and implementation of innovative digital promotion technologies will be essential to this role. You will also collaborate cross-functionally and support media planning, campaign measurement, campaign asset promotional review, and related expense budgets. - Engages in strategic market planning through developing and executing marketing strategies for lung cancer products and indications. - Understands customer needs and preferences to create engaging and effective marketing campaigns. - Oversees the execution of marketing campaigns across various channels, including digital, print, and field-based resources. - Tracks and analyzes marketing campaign performance to identify areas for improvement and provide recommendations for ### Apprentice - Visual Design - Fortrea Holdings Inc - Location: BANGALORE, Karnātaka, India (unspecified) - Salary: Not disclosed - Posted: 2026-06-05 - 401(k) match: listed (not source-backed) - Apply: https://fortrea.wd1.myworkdayjobs.com/Fortrea/job/Bangalore/Apprentice---Visual-Design_263011/apply - Excerpt: Apprentice - Visual Design BANGALORE, Karnātaka, India As a leading global contract research organization (CRO) with a passion for scientific rigor and decades of clinical development experience, Fortrea provides pharmaceutical, biotechnology, and medi... ### Scientist II, Animal Model Development - Tonix Pharmaceuticals Holding Corp - Location: Frederick, MD (unspecified) - Salary: $70K-$120K - Posted: 2026-03-05 - 401(k) match: listed (not source-backed) - Apply: https://job-boards.greenhouse.io/tonixpharmaceuticals/jobs/4170744009 - Excerpt: Scientist II, Animal Model Development Frederick, MD Tonix Pharmaceuticals* is a fully integrated, commercial-stage biotechnology company focused on central nervous system (CNS) and immunology treatments in areas of high unmet medical need. TONMYA® (cyclobenzaprine HCl sublingual tablets 2.8 mg) is the first new treatment for fibromyalgia in adults in more than 15 years. Tonix's CNS commercial infrastructure supports its marketed products, including its acute migraine products, Zembrace® Symtouch® (sumatriptan injection 3 mg) and Tosymra® (sumatriptan nasal spray 10 mg). Tonix is investigating TONMYA® in Phase 2 clinical trials to evaluate its potential in major depressive disorder and acute stress disorder/acute stress reaction. Tonix is also advancing a pipeline of immunology programs, including TNX-4800, a Phase 2 ready long-acting human anti- Borrelia OspA monoclonal antibody (mAb) for the prevention of Lyme disease in the U.S., and TNX-1500, a Phase 2 ready third-generation CD40 ligand inhibitor for the prevention of kidney transplant rejection. In addition, the Company is progressing TNX-2900 (intranasal potentiated oxytocin), which is Phase 2 ready for the treatment of Prader-Willi syndrome, a rare disease. To learn more, visit www.tonixpharma.com and follow the Company on LinkedIn and X . *Tonix's product development candidates are investigational new drugs or biologics; their efficacy and safety have not been established and have not been approved for any indication. Zembrace SymTouch and Tosymra are registered trademarks of Tonix Medicines. TONMYA is a registered trademark of Tonix Pharma Limited. All other marks are property of their respective owners. Position Overview Tonix Research and Development Center ### Apprentice - Employer Branding - Fortrea Holdings Inc - Location: BANGALORE, Karnātaka, India (unspecified) - Salary: Not disclosed - Posted: 2026-06-05 - 401(k) match: listed (not source-backed) - Apply: https://fortrea.wd1.myworkdayjobs.com/Fortrea/job/Bangalore/Apprentice---Employer-Branding_263009/apply - Excerpt: Apprentice - Employer Branding BANGALORE, Karnātaka, India As a leading global contract research organization (CRO) with a passion for scientific rigor and decades of clinical development experience, Fortrea provides pharmaceutical, biotechnology, and medi... ### Manager, Commercial Supply Chain - Revolution Medicines - Location: Redwood City, California, United States (unspecified) - Salary: $143K-$178K - Posted: 2026-05-19 - 401(k) match: listed (not source-backed) - Apply: https://www.revmed.com/careers-list/?gh_jid=7738630003 - Excerpt: Manager, Commercial Supply Chain Redwood City, California, United States Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company's R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company's RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. As a new member of the Revolution Medicines team, you will join other outstanding professionals in a tireless commitment to patients with cancers harboring mutations in the RAS signaling pathway. The Opportunity: Revolution Medicines is seeking a motivated and experienced Manager, Commercial Supply Chain to lead and optimize global distribution and logistics operations supporting commercial pharmaceutical products. This role is responsible for ensuring the compliant, timely, and efficient movement of GMP materials and finished goods across manufacturing sites, depots, CMOs, and 3PL partners. The successful candidate will partner cross-functionally to support commercial scale-up, global distribution expansion, and supply continuity initiatives while driving operational excellence, compliance, and continuous improvement across the commercial supply chain network. Responsibilities: - Plan and execute global distribution and end-to-end logistics operations for commercial products across manufacturing sites, CMOs, depots, and 3PL partners, ensuring compliant shipment execution, documentation, carrier coordination, and on-time delivery performance. - Oversee GMP and temperature-controlled product movements while managing excursions, deviations, investigations, and CAPAs in partnership with Quality. - Manage global trade compliance programs, including import/export controls, customs ### Pharmaceutical Sales Specialist Immunology - Alsace - Regeneron Pharmaceuticals - Location: Remote - France (remote) - Salary: Not disclosed - Posted: 2026-06-08 - Parental leave: 12 weeks (not source-backed) - Non-birth-parent leave: 12 weeks (not source-backed) - 401(k) match: listed (not source-backed) - Apply: https://regeneron.wd1.myworkdayjobs.com/Careers/job/Remote---France/Pharmaceutical-Sales-Specialist-Immunology---Alsace_R47580 - Excerpt: Pharmaceutical Sales Specialist Immunology - Alsace Remote - France posted: Posted 4 Days Ago ### Director, Analytical Development - Revolution Medicines - Location: Redwood City, California, United States (unspecified) - Salary: $211K-$264K - Posted: 2026-05-13 - 401(k) match: listed (not source-backed) - Apply: https://www.revmed.com/careers-list/?gh_jid=7732695003 - Excerpt: Director, Analytical Development Redwood City, California, United States Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company's R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company's RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. As a new member of the Revolution Medicines team, you will join other outstanding professionals in a tireless commitment to patients with cancers harboring mutations in the RAS signaling pathway. The Opportunity: - Provide strategic and organizational leadership for analytical development activities supporting small molecule API and drug product development, including oversight of phase appropriate control strategies, specification setting, analytical lifecycle management, and overall CMC analytical strategy. - Lead and oversee analytical development execution across internal and external teams to support the development, characterization, and manufacturing of API and drug product, while actively contributing to cross functional PDM project teams. - Provide strategic guidance and oversight for regulatory submission activities, including authoring and review Quality sections of regulatory submissions, and leading responses to regulatory queries. - Establish and drive analytical strategies, technology selection, and operational execution through effective management of CDMOs, CROs, and contract laboratories, with accountability for quality, timelines, risk management, and delivery. - Provide leadership oversight for preparation, review, and approval of analytical protocols, reports, specifications, investigations, and technical documentation to ensure scientific excellence, ### Senior Director, Pharmaceutical Strategy and Development Leader - Crinetics Pharmaceuticals INC - Location: San Diego, CA (unspecified) - Salary: $214K-$268K - Posted: 2026-05-12 - 401(k) match: listed (not source-backed) - Apply: https://crinetics.wd12.myworkdayjobs.com/CrineticsCareers/job/San-Diego-CA/Senior-Director--Pharmaceutical-Strategy-and-Development-Leader_JR000446 - Excerpt: Senior Director, Pharmaceutical Strategy and Development Leader San Diego, CA Crinetics is a pharmaceutical company based in San Diego, California that develops much-needed therapies for people with rare endocrine diseases. We were founded by a dedicated team of scientists with the simple belief that better therapies developed from rigorous innovation can lead to better lives. Our work continues to make a real difference in the lives of patients. We have a prolific discovery engine and robust pipeline across preclinical and clinical development. We are driven by science with a patient-centric and team-oriented culture. This is an exciting time to join Crinetics as we shape our organization into the world's premier fully integrated endocrine company from discovery to patients. Come join our team as we transform the lives of others. Position Summary: The Senior Director, Pharmaceutical Development Team Leader (PDTL) is responsible for developing and leading the execution of comprehensive, compound-specific Technical Operations strategies to meet the global project team's (GPT) needs. This role provides leadership to interdisciplinary teams, managing multiple assets through various stages of development, and collaborates with various functional areas to achieve optimal development and business results. Essential Job Functions and Responsibilities: These may include but are not limited to: Develop, refine, update, and oversee Technical Operations project plans from multiple inputs, with emphasis on the alignment of these plans with strategic objectives, the decomposition of major objectives into discrete WBS-level work packages, the mapping of internal and cross-functional interdependencies, and the management of project risks. Perform detailed ### Associate Scientist II (Contract), Conjugation Development - Vaxcyte Inc - Location: San Carlos, California, United States (unspecified) - Salary: $51-$56/hr - Posted: 2026-05-08 - 401(k) match: listed (not source-backed) - Apply: https://boards.greenhouse.io/vaxcyte/jobs/5210608008?gh_jid=5210608008 - Excerpt: Associate Scientist II (Contract), Conjugation Development San Carlos, California, United States Join our Mission to Protect Humankind! Vaxcyte is a clinical-stage vaccine innovation company engineering high-fidelity vaccines to protect humankind from the consequences of bacterial diseases, which have serious and costly health consequences when left unchecked. Working to eradicate or treat bacterial infections such as invasive pneumococcal disease, Group A Strep, and Shigella is just the beginning. Our path to success is clear and well-defined, and Vaxcyte is set up to go the distance. WHAT we do is every bit as important as HOW we do it! Our work together is guided by four enduring core values: *RETHINK CONVENTION: We bring creative and intellectual diversity to every facet of the work we do in order to innovate and re-innovate the way vaccines are delivered. *AIM HIGH: We embody our collectively audacious goal to courageously make the most complex biologics ever attempted to protect humankind. *LEAD WITH HEART: Everyone leads at Vaxcyte with a kindness-first, inclusive approach to collaboration and vigorous debate that advances our business objectives. *MODEL EXCELLENCE: The magnitude of our challenge requires our shared commitment to demonstrating integrity, accountability, equality and clarity across communications and decision making. Summary: Vaxcyte is seeking an Associate Scientist II (Contract), Conjugation Development, who will contribute to the development of a robust process for generating the company's proprietary pneumococcal conjugate vaccine. This role will focus on the synthesis, purification, and analytical characterization of chemically modified polysaccharides and polysaccharide-protein conjugates. The successful candidate will ### Clinical Trial Assistant - Fortrea Holdings Inc - Location: Warsaw, Poland (unspecified) - Salary: Not disclosed - Posted: 2026-04-10 - 401(k) match: listed (not source-backed) - Apply: https://fortrea.wd1.myworkdayjobs.com/Fortrea/job/Warsaw/Clinical-Trial-Assistant_261829/apply - Excerpt: Clinical Trial Assistant Warsaw, Poland Fortrea is looking for an experienced Clinical Trial Assistant to support global clinical studies within an FSP model for a leading pharmaceutical sponsor. What you'll do. Support clinical trials e... ### Senior Director & Therapeutic Area Head, Regulatory Affairs - Revolution Medicines - Location: Redwood City, California, United States (unspecified) - Salary: $244K-$305K - Posted: 2026-04-10 - 401(k) match: listed (not source-backed) - Apply: https://www.revmed.com/careers-list/?gh_jid=7695273003 - Excerpt: Senior Director & Therapeutic Area Head, Regulatory Affairs Redwood City, California, United States Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company's R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company's RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. As a new member of the Revolution Medicines team, you will join other outstanding professionals in a tireless commitment to patients with cancers harboring mutations in the RAS signaling pathway. The Opportunity: - Provide management and leadership of one or more therapeutic areas for late-stage oncology programs. - Oversee the development of global regulatory therapeutic area and product strategies to drive product development, global registration, , and effective regulatory agency interactions. - Provide regulatory expertise and guidance to therapeutic area commercialization teams and other governance bodies. - Foster the career development of staff within the therapeutic area and contribute to departmental leadership activities. - Ensure alignment and consistency across programs within a therapeutic area based on regulatory intel, research, and competitive landscape. Primary Responsibilities: - Direct the development of global regulatory strategy from registrational studies to marketing application across one or more therapeutic areas. - Lead and mentor GRLs/Study Leads in the development of global regulatory strategies, in partnership with regional regulatory leads, including precedence, risk management and contingency planning. - ### Pharmaceutical Technician II - Thermo Fisher Scientific - Location: Singapore, Singapore (unspecified) - Salary: Not disclosed - Posted: 2026-06-11 - 401(k) match: listed (not source-backed) - Apply: https://thermofisher.wd5.myworkdayjobs.com/ThermoFisherCareers/job/Singapore-Singapore/Pharmaceutical-Technician-II_R-01340678/apply - Excerpt: Pharmaceutical Technician II Singapore, Singapore Embrace the role of a Pharmaceutical Technician II and play a vital role in sterile pharmaceutical production. Operate advanced equipment, ensure GMP compliance, and contribute to quality manufacturing. If you have hands-on experience in pharma production and a passion for safety and precision, this is your opportunity to make a difference. ### Senior Associate Scientist (Contract), Upstream Polysaccharide Process Development - Vaxcyte Inc - Location: San Carlos, California, United States (unspecified) - Salary: $56-$62/hr - Posted: 2025-07-22 - 401(k) match: listed (not source-backed) - Apply: https://boards.greenhouse.io/vaxcyte/jobs/4816461008?gh_jid=4816461008 - Excerpt: Senior Associate Scientist (Contract), Upstream Polysaccharide Process Development San Carlos, California, United States Join our Mission to Protect Humankind! Vaxcyte is a clinical-stage vaccine innovation company engineering high-fidelity vaccines to protect humankind from the consequences of bacterial diseases, which have serious and costly health consequences when left unchecked. Working to eradicate or treat bacterial infections such as invasive pneumococcal disease, Group A Strep, and Shigella is just the beginning. Our path to success is clear and well-defined, and Vaxcyte is set up to go the distance. WHAT we do is every bit as important as HOW we do it! Our work together is guided by four enduring core values: *RETHINK CONVENTION: We bring creative and intellectual diversity to every facet of the work we do in order to innovate and re-innovate the way vaccines are delivered. *AIM HIGH: We embody our collectively audacious goal to courageously make the most complex biologics ever attempted to protect humankind. *LEAD WITH HEART: Everyone leads at Vaxcyte with a kindness-first, inclusive approach to collaboration and vigorous debate that advances our business objectives. *MODEL EXCELLENCE: The magnitude of our challenge requires our shared commitment to demonstrating integrity, accountability, equality and clarity across communications and decision making. Summary: The Development organization is comprised of four Process teams: Protein, Polysaccharide, Conjugate Drug Substance (Conjugation), and Drug Product. These Process Development teams are supported by Analytical Development and Formulation Development teams. Vaxcyte is looking for a Senior Associate Scientist (contract) with experience in microbial fermentation and upstream processing ### Sr CRA I - Fortrea Holdings Inc - Location: Buenos Aires, Buenos Aires, Argentina (unspecified) - Salary: Not disclosed - Posted: 2024-12-26 - 401(k) match: listed (not source-backed) - Apply: https://fortrea.wd1.myworkdayjobs.com/Fortrea/job/Buenos-Aires/Sr-CRA-I_2434170/apply - Excerpt: Sr CRA I Buenos Aires, Buenos Aires, Argentina As a leading global contract research organization (CRO) with a passion for scientific rigor and decades of clinical development experience, Fortrea provides pharmaceutical, biotechnology, and medi... ### Senior Director, Organizational Development & Effectiveness - Revolution Medicines - Location: Redwood City, California, United States (unspecified) - Salary: $244K-$305K - Posted: 2026-04-22 - 401(k) match: listed (not source-backed) - Apply: https://www.revmed.com/careers-list/?gh_jid=7711168003 - Excerpt: Senior Director, Organizational Development & Effectiveness Redwood City, California, United States Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company's R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company's RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. As a new member of the Revolution Medicines team, you will join other outstanding professionals in a tireless commitment to patients with cancers harboring mutations in the RAS signaling pathway. The Opportunity: We are seeking a strategic and enterprise-minded leader to build and scale the Organizational Development and Effectiveness function at Revolution Medicines. As Senior Director, Organizational Effectiveness, you will define and drive the long-term strategy for leadership effectiveness, team performance and organizational health to support our rapid growth and strengthen our mission-driven, values-aligned culture. This role partners closely with HR Business Partners, Learning & Development and Senior Leaders across all functions and regions to deliver high-impact organizational programs and solutions to drive team effectiveness. You will design a scalable, data-informed approach that leverages both internal capabilities and an external network of coaches and facilitators to meet evolving business needs. This function will ensure that leaders and teams are equipped to operate effectively at scale, while providing clear insights and interventions that enhance organizational performance across the enterprise. The function will lead both ### Pharmaceutical Technician II - Thermo Fisher Scientific - Location: Singapore, Singapore (unspecified) - Salary: Not disclosed - Posted: 2026-06-11 - 401(k) match: listed (not source-backed) - Apply: https://thermofisher.wd5.myworkdayjobs.com/ThermoFisherCareers/job/Singapore-Singapore/Pharmaceutical-Technician-II_R-01340680-1/apply - Excerpt: Pharmaceutical Technician II Singapore, Singapore Embrace the opportunity to become a Pharmaceutical Technician II and play a vital role in sterile pharmaceutical production. Operate advanced equipment, ensure GMP compliance, and contribute to quality manufacturing. If you have hands-on experience in pharma production and a passion for safety and precision, this is your opportunity to make a difference. ### Principal Product Manager, Clinical Trials Intelligence - Revolution Medicines - Location: Redwood City, California, United States (unspecified) - Salary: $186K-$233K - Posted: 2026-05-19 - 401(k) match: listed (not source-backed) - Apply: https://www.revmed.com/careers-list/?gh_jid=7739001003 - Excerpt: Principal Product Manager, Clinical Trials Intelligence Redwood City, California, United States Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company's R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company's RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. As a new member of the Revolution Medicines team, you will join other outstanding professionals in a tireless commitment to patients with cancers harboring mutations in the RAS signaling pathway. The Opportunity: We are seeking a Principal Product Manager, Clinical Trials Intelligence to build products that help teams plan, run, monitor, analyze, submit, and follow clinical trials with greater speed, quality, and confidence.This role will define and deliver product strategy across the clinical trial continuum, from study design and startup through trial conduct, submission readiness, and post-approval safety monitoring. You will shape Clinical Trials Intelligence capabilities on RevCore, our enterprise data and AI platform, with a clear mandate to improve trial execution, enrollment predictability, data readiness, submission readiness, inspection readiness, and safety monitoring. You will work on high-stakes products where trust, usability, traceability, and speed directly affect trial execution, regulatory readiness, and patient impact. This role focuses on product strategy, user outcomes, workflow design, adoption, and measurable impact, in partnership with clinical, regulatory, safety, medical, data, technology, quality, vendor, and system owner teams. ### Pharmaceutical Sciences, Technology & Innovation Lead (Sr. Director) - Takeda Pharmaceutical Company Limited - Location: Boston, MA (unspecified) - Salary: Not disclosed - Posted: 2026-06-11 - 401(k) match: listed (not source-backed) - Apply: https://takeda.wd3.myworkdayjobs.com/External/job/Boston-MA/Pharmaceutical-Sciences--Technology---Innovation-Lead--Sr-Director-_R0178501-1 - Excerpt: Pharmaceutical Sciences, Technology & Innovation Lead (Sr. Director) Boston, MA posted: Posted Yesterday ### Manager, Corporate Strategy and CEO Initiatives - Tonix Pharmaceuticals Holding Corp - Location: Berkeley Heights, NJ (unspecified) - Salary: $90K-$150K - Posted: 2026-06-04 - 401(k) match: listed (not source-backed) - Apply: https://job-boards.greenhouse.io/tonixpharmaceuticals/jobs/4272302009 - Excerpt: Manager, Corporate Strategy and CEO Initiatives Berkeley Heights, NJ Tonix Pharmaceuticals* is a fully integrated, commercial-stage biotechnology company focused on central nervous system (CNS) and immunology treatments in areas of high unmet medical need. TONMYA® (cyclobenzaprine HCl sublingual tablets 2.8 mg) is the first new treatment for fibromyalgia in adults in more than 15 years. Tonix's CNS commercial infrastructure supports its marketed products, including its acute migraine products, Zembrace® Symtouch® (sumatriptan injection 3 mg) and Tosymra® (sumatriptan nasal spray 10 mg). Tonix is investigating TONMYA® in Phase 2 clinical trials to evaluate its potential in major depressive disorder and acute stress disorder/acute stress reaction. Tonix is also advancing a pipeline of immunology programs, including TNX-4800, a Phase 2 ready long-acting human anti- Borrelia OspA monoclonal antibody (mAb) for the prevention of Lyme disease in the U.S., and TNX-1500, a Phase 2 ready third-generation CD40 ligand inhibitor for the prevention of kidney transplant rejection. In addition, the Company is progressing TNX-2900 (intranasal potentiated oxytocin), which is Phase 2 ready for the treatment of Prader-Willi syndrome, a rare disease. To learn more, visit www.tonixpharma.com and follow the Company on LinkedIn and X . *Tonix's product development candidates are investigational new drugs or biologics; their efficacy and safety have not been established and have not been approved for any indication. Zembrace SymTouch and Tosymra are registered trademarks of Tonix Medicines. TONMYA is a registered trademark of Tonix Pharma Limited. All other marks are property of their respective owners. Position Overview The Manager, Corporate ### Pharmaceutical Sciences, Operations & Performance Lead (Sr. Director) - Takeda Pharmaceutical Company Limited - Location: Boston, MA (unspecified) - Salary: Not disclosed - Posted: 2026-05-12 - 401(k) match: listed (not source-backed) - Apply: https://takeda.wd3.myworkdayjobs.com/External/job/Boston-MA/Pharmaceutical-Sciences--Strategy---Operations-Lead--Sr-Director-_R0178498 - Excerpt: Pharmaceutical Sciences, Operations & Performance Lead (Sr. Director) Boston, MA posted: Posted 30+ Days Ago ### Associate Engineer II (Contract), Polysaccharide Manufacturing - Vaxcyte Inc - Location: San Carlos, California, United States (unspecified) - Salary: $51-$56/hr - Posted: 2026-03-27 - 401(k) match: listed (not source-backed) - Apply: https://boards.greenhouse.io/vaxcyte/jobs/5168436008?gh_jid=5168436008 - Excerpt: Associate Engineer II (Contract), Polysaccharide Manufacturing San Carlos, California, United States Join our Mission to Protect Humankind! Vaxcyte is a clinical-stage vaccine innovation company engineering high-fidelity vaccines to protect humankind from the consequences of bacterial diseases, which have serious and costly health consequences when left unchecked. Working to eradicate or treat bacterial infections such as invasive pneumococcal disease, Group A Strep, and Shigella is just the beginning. Our path to success is clear and well-defined, and Vaxcyte is set up to go the distance. WHAT we do is every bit as important as HOW we do it! Our work together is guided by four enduring core values: *RETHINK CONVENTION: We bring creative and intellectual diversity to every facet of the work we do in order to innovate and re-innovate the way vaccines are delivered. *AIM HIGH: We embody our collectively audacious goal to courageously make the most complex biologics ever attempted to protect humankind. *LEAD WITH HEART: Everyone leads at Vaxcyte with a kindness-first, inclusive approach to collaboration and vigorous debate that advances our business objectives. *MODEL EXCELLENCE: The magnitude of our challenge requires our shared commitment to demonstrating integrity, accountability, equality and clarity across communications and decision making. Summary: The Development organization is comprised of four Process teams: Protein, Polysaccharide, Conjugate Drug Substance (Conjugation), and Drug Product. These Process Development teams are supported by Analytical Development and Formulation Development teams. Vaxcyte is seeking an Associate Engineer II with experience or strong foundational knowledge in vaccine or biologics process development ### Associate Director or Principal Scientist, Facility Operations, Pharmaceutical Sciences - Takeda Pharmaceutical Company Limited - Location: Fujisawa, Japan (unspecified) - Salary: Not disclosed - Posted: 2026-05-12 - 401(k) match: listed (not source-backed) - Apply: https://takeda.wd3.myworkdayjobs.com/External/job/Fujisawa-Japan/Associate-Director-or-Principal-Scientist--Facility-Operations--Pharmaceutical-Sciences_R0178525-1 - Excerpt: Associate Director or Principal Scientist, Facility Operations, Pharmaceutical Sciences Fujisawa, Japan posted: Posted 30+ Days Ago ### Senior Manager, Trade and Distribution - Cogent Biosciences Inc - Location: Waltham, Massachusetts, United States (unspecified) - Salary: $175K-$205K - Posted: 2026-03-25 - 401(k) match: listed (not source-backed) - Learning budget: yes (not source-backed) - Apply: https://job-boards.greenhouse.io/cogentbiosciences/jobs/4195598009 - Excerpt: Senior Manager, Trade and Distribution Waltham, Massachusetts, United States Who We Are: Cogent Biosciences is a publicly traded biotechnology company focused on developing novel precision therapies to treat a broad range of patients with unmet medical needs. Cogent's lead program, bezuclastinib, is designed to selectively and potently inhibit exon 17 mutations found within the KIT receptor tyrosine kinase, including KIT D816V. KIT D816V is responsible for driving a rare and serious condition called Systemic Mastocytosis, and exon 17 mutations are also found in patients with gastrointestinal stromal tumors (GIST), a type of cancer with strong dependence on oncogenic KIT signaling. Bezuclastinib has exhibited promising initial data across all three trials: APEX in AdvSM, SUMMIT in NonAdvSM and PEAK in GIST, including an encouraging safety profile across 600+ patients in single agent and combination dosing. The Role: The Senior Manager of Trade and Distribution will be responsible for management of Cogent Bioscience's network of Specialty Distributor accounts. The Key responsibilities will be to oversee the physical and financial flow of the Cogent Biosciences portfolio beginning with the launch of Bezuclastinib. The candidate will be the primary for Specialty Distributor customers tasked with maintaining relationships and growing Cogent Biosciences business while contributing to the evolving channel strategy for products. This candidate will oversee all aspects of business operations within assigned customers including inventory management, product fulfillment, data flow and management of returns. The individual will report to the Executive Director Trade & Distribution within the Market Access team and work closely with ### Principal or Associate Scientist, Analytical Development Japan, Pharmaceutical Sciences - Takeda Pharmaceutical Company Limited - Location: Fujisawa, Japan (unspecified) - Salary: Not disclosed - Posted: 2026-05-12 - 401(k) match: listed (not source-backed) - Apply: https://takeda.wd3.myworkdayjobs.com/External/job/Fujisawa-Japan/Principal-or-Associate-Scientist--Analytical-Development-Japan--Pharmaceutical-Sciences_R0177837-1 - Excerpt: Principal or Associate Scientist, Analytical Development Japan, Pharmaceutical Sciences Fujisawa, Japan posted: Posted 30+ Days Ago ### Senior Manager, Supply Chain Planner - Vaxcyte Inc - Location: San Carlos, California, United States (unspecified) - Salary: $176K-$205K - Posted: 2026-04-16 - 401(k) match: listed (not source-backed) - Apply: https://boards.greenhouse.io/vaxcyte/jobs/5188916008?gh_jid=5188916008 - Excerpt: Senior Manager, Supply Chain Planner San Carlos, California, United States Join our Mission to Protect Humankind! Vaxcyte is a clinical-stage vaccine innovation company engineering high-fidelity vaccines to protect humankind from the consequences of bacterial diseases, which have serious and costly health consequences when left unchecked. Working to eradicate or treat bacterial infections such as invasive pneumococcal disease, Group A Strep, and Shigella is just the beginning. Our path to success is clear and well-defined, and Vaxcyte is set up to go the distance. WHAT we do is every bit as important as HOW we do it! Our work together is guided by four enduring core values: *RETHINK CONVENTION: We bring creative and intellectual diversity to every facet of the work we do in order to innovate and re-innovate the way vaccines are delivered. *AIM HIGH: We embody our collectively audacious goal to courageously make the most complex biologics ever attempted to protect humankind. *LEAD WITH HEART: Everyone leads at Vaxcyte with a kindness-first, inclusive approach to collaboration and vigorous debate that advances our business objectives. *MODEL EXCELLENCE: The magnitude of our challenge requires our shared commitment to demonstrating integrity, accountability, equality and clarity across communications and decision making. Summary: Vaxcyte is seeking a strategic and execution-focused Senior Manager, Supply Chain Planner to join our Supply Chain Planning Team. This role is responsible for leading end-to-end supply planning across clinical and commercial programs, including demand and supply planning, capacity management, inventory strategy, and scenario analysis. The ideal candidate brings deep experience ### Principal or Associate Scientist, Analytical Development Japan (Late Stage), Pharmaceutical Sciences - Takeda Pharmaceutical Company Limited - Location: Fujisawa, Japan (unspecified) - Salary: Not disclosed - Posted: 2026-06-12 - 401(k) match: listed (not source-backed) - Apply: https://takeda.wd3.myworkdayjobs.com/External/job/Fujisawa-Japan/Principal-or-Associate-Scientist--Analytical-Development-Japan--Late-Stage---Pharmaceutical-Sciences_R0181177-1 - Excerpt: Principal or Associate Scientist, Analytical Development Japan (Late Stage), Pharmaceutical Sciences Fujisawa, Japan posted: Posted Today ### Director, Medical Science Liaison (Dallas, AR, LA, OK, MS) - Revolution Medicines - Location: Remote (United States) (remote) - Salary: $236K-$259K - Posted: 2026-05-19 - 401(k) match: listed (not source-backed) - Apply: https://www.revmed.com/careers-list/?gh_jid=7739035003 - Excerpt: Director, Medical Science Liaison (Dallas, AR, LA, OK, MS) Remote (United States) Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company's R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company's RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. As a new member of the Revolution Medicines team, you will join other outstanding professionals in a tireless commitment to patients with cancers harboring mutations in the RAS signaling pathway. The Opportunity: We are seeking a highly motivated and experienced professional to join our team as a Lung Medical Science Liaison. Key aspects of this role will include engage in peer-to-peer scientific dialogue with healthcare professionals that translate into meaningful insights, serve as a therapeutic expert and thought partner to internal teams, liaison between Revolution Medicines and clinical study sites / investigators, and provide support for medical education, advisory boards, and medical congresses. Medical Science Liaisons (MSLs) are an essential member of the Medical Affairs team who will work as an extension of the Medical Affairs organization. The Lung MSL team will serve as a key liaison between Revolution Medicines and healthcare professionals. Within an assigned geographic territory, the MSL will be responsible for cultivating and strengthening professional relationships with key opinion leaders (KOLs), healthcare providers, and academic centers of excellence involved ### Lead Director, Pharmaceutical Contracting - CVS Health Corporation - Location: Work at Home, Illinois, United States (unspecified) - Salary: Not disclosed - Posted: 2026-06-10 - Non-birth-parent leave: 4 weeks (not source-backed) - 401(k) match: listed (not source-backed) - Apply: https://cvshealth.wd1.myworkdayjobs.com/CVS_Health_Careers/job/IL---Downers-Grove/Lead-Director--Pharmaceutical-Contracting_R0933942/apply - Excerpt: Lead Director, Pharmaceutical Contracting Work at Home, Illinois, United States Join us as Lead Director, Pharmaceutical Contracting and drive high-impact negotiations with major pharmaceutical manufacturers. Shape strategy, foster partnerships, and lead rebate initiatives in a dynamic healthcare environment. If you excel in complex contract negotiations and thrive in leadership roles, this is your opportunity to make a significant impact. ### Payroll Manager - Revolution Medicines - Location: Redwood City, California, United States (unspecified) - Salary: $143K-$178K - Posted: 2026-04-10 - 401(k) match: listed (not source-backed) - Apply: https://www.revmed.com/careers-list/?gh_jid=7695380003 - Excerpt: Payroll Manager Redwood City, California, United States Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company's R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company's RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. As a new member of the Revolution Medicines team, you will join other outstanding professionals in a tireless commitment to patients with cancers harboring mutations in the RAS signaling pathway. The Opportunity: Reporting to the Associate Director, Payroll, the Payroll Manager will be responsible for ensuring accurate, timely and compliant payroll processing from start to finish. This position is ideal for a payroll leader who thrives in fast-paced, ambiguous, and rapidly growing environments. The successful candidate will have deep experience in public company environments, understand stock compensation, and be well-versed in SOX compliance, audits, and employment tax. Responsibilities: - Manage full-cycle operations for the US payroll including but not limited to semi-monthly, equity, commission, off-cycle and bonus processing using ADP Workforce Now. - Support equity compensation processing including RSU, ISO, Non-Qual, and ESPP; ensuring accurate tax treatment and timely reporting. - Supervise and mentor a team of payroll professionals, providing leadership, development, and training. - Lead quarter-end and year-end payroll processes, including tax reporting, compliance filings and W-2/equivalent statement delivery. - Ensure compliance with local payroll, tax, ### Associate Director, Commercial Supply Planning - Kalvista Pharmaceuticals INC - Location: Framingham, US (unspecified) - Salary: $175K-$205K - Posted: 2026-03-20 - Apply: https://job-boards.greenhouse.io/kalvistapharmaceuticals/jobs/5160427008 - Excerpt: Associate Director, Commercial Supply Planning Framingham, US About KalVista Pharmaceuticals, Inc. KalVista is a global pharmaceutical company dedicated to delivering life-changing oral therapies for individuals affected by rare diseases with significant unmet needs. The KalVista team discovered and developed EKTERLY®-the first and only oral on-demand treatment for hereditary angioedema (HAE)-and continues to work closely with the global HAE community to improve treatment and care for this disease around the world. For more information about KalVista, please visit www.kalvista.com and follow us on LinkedIn , X , Facebook and Instagram . ABOUT THE ROLE KalVista seeks a highly motivated and knowledgeable professional to join us as Associate Director, Commercial Supply Planning. Reporting to the Senior Director, Supply Planning and Network Strategy, this role will lead supply planning activities for both US and Global Commercial programs. As a key member of the planning team, you will develop an all-encompassing strategy focusing on New Product Introduction (NPI) to lifecycle management of all marketed products at KalVista. This role will also place a high emphasis on planning in an ERP environment (SAP), along with reporting the “health” of our supply chain through generation of robust metrics and KPIs. Our ideal candidate will possess a strong skillset required to translate fluid forecasts into working production plans, pre and post launch activities and aligning cross functionally in execution of product to patient. RESPONSIBILITIES Maintain target level of end-to-end supply across all regions. Ensure demand and supply are accurately reflected and executed in SAP Oversee the Supply ### Regional Insights and Engagement Director, Northeast - Revolution Medicines - Location: Redwood City, California, United States (unspecified) - Salary: $231K-$254K - Posted: 2026-05-20 - 401(k) match: listed (not source-backed) - Apply: https://www.revmed.com/careers-list/?gh_jid=7732653003 - Excerpt: Regional Insights and Engagement Director, Northeast Redwood City, California, United States Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company's R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company's RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. As a new member of the Revolution Medicines team, you will join other outstanding professionals in a tireless commitment to patients with cancers harboring mutations in the RAS signaling pathway. The Opportunity: The Regional Insights and Engagement Director, Northeast is a field-based position focused on working closely with Lung Cancer Key Opinion Leaders (KOLs) at select institutions and accounts within the defined geography. This person is a RevMed clinical and product expert for Key Opinion Leaders and ensures that cross-functional resources are made available as appropriate. In this role, you will be a member of the commercial development team, and you will work closely with marketing, medical affairs, field sales, insights and analytics and other cross functional colleagues. You will help inform brand strategy, develop and execute KOL tactics and you will be evaluated in conjunction with individual performance and brand KPIs. This role will cover major academic institutions, accounts, and the Lung Key Opinion Leaders located in the Northeast. Essential Duties: - Designs, executes, and implements significant national strategic marketing deliverables. - ### Senior Research Associate/Senior Scientist, Pharmaceutical Development - Ionis Pharmaceuticals - Location: 2280 Faraday-USA; 2830 Whiptail (unspecified) - Salary: Not disclosed - Posted: 2026-06-05 - 401(k) match: listed (not source-backed) - Apply: https://recruiting.ultipro.com/isi1000isis/JobBoard/14a66400-68fa-4847-8593-af776328cfd2/OpportunityDetail?opportunityId=ad2d13f5-0499-4011-b6d6-e4be422f0485 - Excerpt: Senior Research Associate/Senior Scientist, Pharmaceutical Development 2280 Faraday-USA; 2830 Whiptail Ionis Pharmaceuticals seeks an experienced pharmaceutical development scientist to support laboratory experiments, review development data, and author and standardize technical reports for injectable drug products in development. The ideal candidate will be an independent self-starter with experience in analytical, formulation and process support for early and late-stage development of oligonucleotide-based drug products including conjugated with small molecules, peptides and proteins. The successful candidate will be able to perform the following responsibilities with a high degree of independence and attention to detail. ### Director, Medical Science Liaison, California - Revolution Medicines - Location: Remote (United States) (remote) - Salary: $236K-$259K - Posted: 2026-04-24 - 401(k) match: listed (not source-backed) - Apply: https://www.revmed.com/careers-list/?gh_jid=7714055003 - Excerpt: Director, Medical Science Liaison, California Remote (United States) Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company's R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company's RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. As a new member of the Revolution Medicines team, you will join other outstanding professionals in a tireless commitment to patients with cancers harboring mutations in the RAS signaling pathway. The Opportunity: We are seeking a highly motivated and experienced professional to join our team as a Medical Science Liaison. Key aspects of this role will include engage in peer-to-peer scientific dialogue with healthcare professionals that translate into meaningful insights, serve as a therapeutic expert and thought partner to internal teams, liaison between Revolution Medicines and clinical study sites / investigators, and provide support for medical education, advisory boards, and medical congresses. Medical Science Liaisons (MSLs) are an essential member of the Medical Affairs team who will work as an extension of the Medical Affairs organization. The MSL team will serve as a key liaison between Revolution Medicines and healthcare professionals. Within an assigned geographic territory, the MSL will be responsible for cultivating and strengthening professional relationships with key opinion leaders (KOLs), healthcare providers, and academic centers of excellence involved in various phases of product development. ### Senior Legal Counsel - Pharmaceutical Contracting - CVS Health Corporation - Location: One CVS Drive, Woonsocket, Rhode Island,United States (unspecified) - Salary: Not disclosed - Posted: 2026-05-26 - Non-birth-parent leave: 4 weeks (not source-backed) - 401(k) match: listed (not source-backed) - Apply: https://cvshealth.wd1.myworkdayjobs.com/CVS_Health_Careers/job/RI---Woonsocket/Senior-Legal-Counsel---Pharmaceutical-Contracting_R0901888/apply - Excerpt: Senior Legal Counsel - Pharmaceutical Contracting One CVS Drive, Woonsocket, Rhode Island,United States Join our team as a Senior Legal Counsel - Pharmaceutical Contracting and play a pivotal role in shaping healthcare solutions. Advise on complex retail trade and pharmaceutical agreements, ensure regulatory compliance, and collaborate with cross-functional teams. Make a meaningful impact in a dynamic environment dedicated to innovation and patient care. ### Manager, Trade & Market Access - Tonix Pharmaceuticals Holding Corp - Location: Berkeley Heights, NJ (unspecified) - Salary: $90K-$150K - Posted: 2026-03-05 - 401(k) match: listed (not source-backed) - Apply: https://job-boards.greenhouse.io/tonixpharmaceuticals/jobs/4170833009 - Excerpt: Manager, Trade & Market Access Berkeley Heights, NJ Tonix Pharmaceuticals* is a fully integrated, commercial-stage biotechnology company focused on central nervous system (CNS) and immunology treatments in areas of high unmet medical need. TONMYA® (cyclobenzaprine HCl sublingual tablets 2.8 mg) is the first new treatment for fibromyalgia in adults in more than 15 years. Tonix's CNS commercial infrastructure supports its marketed products, including its acute migraine products, Zembrace® Symtouch® (sumatriptan injection 3 mg) and Tosymra® (sumatriptan nasal spray 10 mg). Tonix is investigating TONMYA® in Phase 2 clinical trials to evaluate its potential in major depressive disorder and acute stress disorder/acute stress reaction. Tonix is also advancing a pipeline of immunology programs, including TNX-4800, a Phase 2 ready long-acting human anti- Borrelia OspA monoclonal antibody (mAb) for the prevention of Lyme disease in the U.S., and TNX-1500, a Phase 2 ready third-generation CD40 ligand inhibitor for the prevention of kidney transplant rejection. In addition, the Company is progressing TNX-2900 (intranasal potentiated oxytocin), which is Phase 2 ready for the treatment of Prader-Willi syndrome, a rare disease. To learn more, visit www.tonixpharma.com and follow the Company on LinkedIn and X . *Tonix's product development candidates are investigational new drugs or biologics; their efficacy and safety have not been established and have not been approved for any indication. Zembrace SymTouch and Tosymra are registered trademarks of Tonix Medicines. TONMYA is a registered trademark of Tonix Pharma Limited. All other marks are property of their respective owners. Position Overview The Manager of Trade ### Pharmaceutical Assistant - Pfizer - Location: United States - Kansas - McPherson (unspecified) - Salary: Not disclosed - Posted: 2026-06-12 - Parental leave: 12 weeks (not source-backed) - Non-birth-parent leave: 12 weeks (not source-backed) - 401(k) match: listed (not source-backed) - Apply: https://pfizer.wd1.myworkdayjobs.com/PfizerCareers/job/United-States---Kansas---McPherson/Pharmaceutical-Assistant_4954329-1 - Excerpt: Pharmaceutical Assistant United States - Kansas - McPherson posted: Posted Today ### Pharmaceutical Attendant - Pfizer - Location: United States - Kansas - McPherson (unspecified) - Salary: Not disclosed - Posted: 2026-06-11 - Parental leave: 12 weeks (not source-backed) - Non-birth-parent leave: 12 weeks (not source-backed) - 401(k) match: listed (not source-backed) - Apply: https://pfizer.wd1.myworkdayjobs.com/PfizerCareers/job/United-States---Kansas---McPherson/Pharmaceutical-Attendant_4956657-1 - Excerpt: Pharmaceutical Attendant United States - Kansas - McPherson posted: Posted Yesterday ### Manager/Sr. Manager QA Supply Chain - Oruka Therapeutics Inc - Location: Waltham, Massachusetts, United States (unspecified) - Salary: $146K-$187K - Posted: 2026-05-28 - Apply: https://job-boards.greenhouse.io/oruka/jobs/5234862008 - Excerpt: Manager/Sr. Manager QA Supply Chain Waltham, Massachusetts, United States About Us: Oruka Therapeutics (Nasdaq: ORKA) is developing novel biologics designed to set a new standard for the treatment of chronic skin diseases. Oruka's mission is to offer patients suffering from chronic skin diseases like plaque psoriasis the greatest possible freedom from their condition by achieving high rates of complete disease clearance with dosing as infrequently as once or twice per year. Oruka is advancing a proprietary portfolio of potentially best-in-class antibodies that were engineered by Paragon Therapeutics and target the core mechanisms underlying plaque psoriasis and other dermatologic and inflammatory diseases. For more information, visit www.orukatx.com As we build our core team, we're seeking top talent in different functional areas who are not just looking for a job, but an opportunity to be part of something bigger. Someone who is passionate about making a difference and eager to contribute to establishing an engaged, inclusive, and positive company culture. Job Title: Manager / Senior Manager, QA Supply Chain Location: Hybrid - Waltham, MA . Candidates will be required to be in-office 3 days/week. Role Overview: The Manager / Senior Manager, QA Supply Chain is responsible for providing quality oversight of clinical supply chain activities supporting Phase 2 and Phase 3 programs, including packaging, labeling, distribution, and cold chain management. This role ensures inspection readiness and compliance across all clinical supply operations. This role ensures that all supply chain operations are conducted in compliance with cGMP, GCP, and GDP requirements, with a ### Executive Director, Healthcare Law and Market Access - Revolution Medicines - Location: Redwood City, California, United States (unspecified) - Salary: $311K-$357K - Posted: 2026-06-02 - 401(k) match: listed (not source-backed) - Apply: https://www.revmed.com/careers-list/?gh_jid=7648505003 - Excerpt: Executive Director, Healthcare Law and Market Access Redwood City, California, United States Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company's R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company's RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. As a new member of the Revolution Medicines team, you will join other outstanding professionals in a tireless commitment to patients with cancers harboring mutations in the RAS signaling pathway. The Opportunity: We are seeking an Executive Director, Healthcare Law and Market Access reporting to the Vice President, Healthcare Law to join our RevMed team. The Executive Director, Healthcare Law and Market Access will serve as the zoldonrasib Legal brand lead and provide strategic legal guidance related to the company's planned zoldonrasib commercialization activities, patient access programs, distribution and licensing, and regulatory submissions. In addition, the position will serve as the senior enterprise legal leader responsible for shaping and advancing Revolution Medicines' U.S. Market Access legal strategy in support of commercialization, patient access, pricing, reimbursement, and corporate growth objectives. At a tactical level, the position will be responsible for managing all aspects of Market Access contracting through product distribution channels, including distributors, specialty distributors, specialty pharmacies, 3 rd party logistics providers and payers, and government pricing and reimbursement. A successful candidate will ### Research Tech I (Daytona Beach, FL/on-site) - Fortrea Holdings Inc - Location: Daytona Beach, Florida, United States of America (onsite) - Salary: Not disclosed - Posted: 2026-04-06 - 401(k) match: listed (not source-backed) - Apply: https://fortrea.wd1.myworkdayjobs.com/Fortrea/job/Daytona-Beach/Research-Tech-I--Daytona-Beach--FL-on-site-_261664/apply - Excerpt: Research Tech I (Daytona Beach, FL/on-site) Daytona Beach, Florida, United States of America Job Description. As a leading global contract research organization (CRO) with a passion for scientific rigor and decades of clinical development experience, Fortrea provides pharmaceutical, biotec... ### Senior Director, Product Launch Lead VAX-31 - Vaxcyte Inc - Location: San Carlos, California, United States (unspecified) - Salary: $271K-$316K - Posted: 2026-01-20 - 401(k) match: listed (not source-backed) - Apply: https://boards.greenhouse.io/vaxcyte/jobs/5071525008?gh_jid=5071525008 - Excerpt: Senior Director, Product Launch Lead VAX-31 San Carlos, California, United States Join our Mission to Protect Humankind! Vaxcyte is a clinical-stage vaccine innovation company engineering high-fidelity vaccines to protect humankind from the consequences of bacterial diseases, which have serious and costly health consequences when left unchecked. Working to eradicate or treat bacterial infections such as invasive pneumococcal disease, Group A Strep, and Shigella is just the beginning. Our path to success is clear and well-defined, and Vaxcyte is set up to go the distance. WHAT we do is every bit as important as HOW we do it! Our work together is guided by four enduring core values: *RETHINK CONVENTION: We bring creative and intellectual diversity to every facet of the work we do in order to innovate and re-innovate the way vaccines are delivered. *AIM HIGH: We embody our collectively audacious goal to courageously make the most complex biologics ever attempted to protect humankind. *LEAD WITH HEART: Everyone leads at Vaxcyte with a kindness-first, inclusive approach to collaboration and vigorous debate that advances our business objectives. *MODEL EXCELLENCE: The magnitude of our challenge requires our shared commitment to demonstrating integrity, accountability, equality and clarity across communications and decision making. Summary: Vaxcyte is seeking a Senior Director, Launch Lead, VAX-31, to lead strategic planning and execution of the company's first launch of VAX-31. This role will coordinate cross-functional activities from late-stage development through market entry, ensuring readiness across supply chain, regulatory, medical affairs, commercial operations, communications, and other functions. The position ### Pharmaceutical Process Expert (PPE) - Ipsen - Location: Wrexham (unspecified) - Salary: Not disclosed - Posted: 2026-05-12 - 401(k) match: listed (not source-backed) - Apply: https://ipsen.wd103.myworkdayjobs.com/Ipsen_Careers/job/Wrexham/Pharmaceutical-Process-Expert--PPE-_R-21479 - Excerpt: Pharmaceutical Process Expert (PPE) Wrexham posted: Posted 30+ Days Ago ### Director, Medical Science Liaison (AZ, CO, NM, NV) - Revolution Medicines - Location: Remote (United States) (remote) - Salary: $236K-$259K - Posted: 2026-05-19 - 401(k) match: listed (not source-backed) - Apply: https://www.revmed.com/careers-list/?gh_jid=7739033003 - Excerpt: Director, Medical Science Liaison (AZ, CO, NM, NV) Remote (United States) Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company's R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company's RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. As a new member of the Revolution Medicines team, you will join other outstanding professionals in a tireless commitment to patients with cancers harboring mutations in the RAS signaling pathway. The Opportunity: We are seeking a highly motivated and experienced professional to join our team as a Lung Medical Science Liaison. Key aspects of this role will include engage in peer-to-peer scientific dialogue with healthcare professionals that translate into meaningful insights, serve as a therapeutic expert and thought partner to internal teams, liaison between Revolution Medicines and clinical study sites / investigators, and provide support for medical education, advisory boards, and medical congresses. Medical Science Liaisons (MSLs) are an essential member of the Medical Affairs team who will work as an extension of the Medical Affairs organization. The Lung MSL team will serve as a key liaison between Revolution Medicines and healthcare professionals. Within an assigned geographic territory, the MSL will be responsible for cultivating and strengthening professional relationships with key opinion leaders (KOLs), healthcare providers, and academic centers of excellence involved in ### Account Manager - Pharmaceutical - Amcor - Location: 16 Locations (unspecified) - Salary: Not disclosed - Posted: 2026-05-12 - 401(k) match: listed (not source-backed) - Apply: https://amcor.wd5.myworkdayjobs.com/Amcor_External_Career_Site/job/AF-Deerfield-IL-Corporate/Account-Manager---Pharmaceutical_REQ_89081 - Excerpt: Account Manager - Pharmaceutical 16 Locations posted: Posted 30+ Days Ago ### Director, Immunoassay Development - Vaxcyte Inc - Location: San Carlos, California, United States (unspecified) - Salary: $213K-$250K - Posted: 2026-02-26 - 401(k) match: listed (not source-backed) - Apply: https://boards.greenhouse.io/vaxcyte/jobs/5131868008?gh_jid=5131868008 - Excerpt: Director, Immunoassay Development San Carlos, California, United States Join our Mission to Protect Humankind! Vaxcyte is a clinical-stage vaccine innovation company engineering high-fidelity vaccines to protect humankind from the consequences of bacterial diseases, which have serious and costly health consequences when left unchecked. Working to eradicate or treat bacterial infections such as invasive pneumococcal disease, Group A Strep, and Shigella is just the beginning. Our path to success is clear and well-defined, and Vaxcyte is set up to go the distance. WHAT we do is every bit as important as HOW we do it! Our work together is guided by four enduring core values: *RETHINK CONVENTION: We bring creative and intellectual diversity to every facet of the work we do in order to innovate and re-innovate the way vaccines are delivered. *AIM HIGH: We embody our collectively audacious goal to courageously make the most complex biologics ever attempted to protect humankind. *LEAD WITH HEART: Everyone leads at Vaxcyte with a kindness-first, inclusive approach to collaboration and vigorous debate that advances our business objectives. *MODEL EXCELLENCE: The magnitude of our challenge requires our shared commitment to demonstrating integrity, accountability, equality and clarity across communications and decision making. Summary: Vaxcyte is seeking an accomplished Director, Immunoassay Development to establish and lead a dedicated analytical function focused on immunoassay development for complex conjugated vaccines. This role will build and manage a laboratory-based team responsible for developing, sustaining, and continuously improving potency- and antigenicity-based immunoassays to support CMC development from preclinical through BLA-stage programs ### M23 Pharmaceutical Attendant - Pfizer - Location: United States - Kansas - McPherson (unspecified) - Salary: Not disclosed - Posted: 2026-06-11 - Parental leave: 12 weeks (not source-backed) - Non-birth-parent leave: 12 weeks (not source-backed) - 401(k) match: listed (not source-backed) - Apply: https://pfizer.wd1.myworkdayjobs.com/PfizerCareers/job/United-States---Kansas---McPherson/M23-Pharmaceutical-Attendant_4956770-2 - Excerpt: M23 Pharmaceutical Attendant United States - Kansas - McPherson posted: Posted Yesterday ### Senior Associate Scientist (Contract), Polysaccharide Analytical Development - Vaxcyte Inc - Location: San Carlos, California, United States (unspecified) - Salary: $56-$62/hr - Posted: 2026-03-17 - 401(k) match: listed (not source-backed) - Apply: https://boards.greenhouse.io/vaxcyte/jobs/4671584008?gh_jid=4671584008 - Excerpt: Senior Associate Scientist (Contract), Polysaccharide Analytical Development San Carlos, California, United States Join our Mission to Protect Humankind! Vaxcyte is a clinical-stage vaccine innovation company engineering high-fidelity vaccines to protect humankind from the consequences of bacterial diseases, which have serious and costly health consequences when left unchecked. Working to eradicate or treat bacterial infections such as invasive pneumococcal disease, Group A Strep, and Shigella is just the beginning. Our path to success is clear and well-defined, and Vaxcyte is set up to go the distance. WHAT we do is every bit as important as HOW we do it! Our work together is guided by four enduring core values: *RETHINK CONVENTION: We bring creative and intellectual diversity to every facet of the work we do in order to innovate and re-innovate the way vaccines are delivered. *AIM HIGH: We embody our collectively audacious goal to courageously make the most complex biologics ever attempted to protect humankind. *LEAD WITH HEART: Everyone leads at Vaxcyte with a kindness-first, inclusive approach to collaboration and vigorous debate that advances our business objectives. *MODEL EXCELLENCE: The magnitude of our challenge requires our shared commitment to demonstrating integrity, accountability, equality and clarity across communications and decision making. Summary: We are seeking a highly motivated and detail-oriented Senior Associate Scientist (Contract) to join our Polysaccharide team. Primary responsibility for the incumbent will be to support analytical testing and characterization of polysaccharide-based drug candidates. This individual will execute and optimize a variety of biochemical and chromatographic assays, contribute to ### Senior Analyst - Pharmaceutical Markets - IQVIA - Location: Madrid, Spain (unspecified) - Salary: Not disclosed - Posted: 2026-05-12 - 401(k) match: listed (not source-backed) - Apply: https://iqvia.wd1.myworkdayjobs.com/IQVIA/job/Madrid-Spain/Senior-Analyst---Pharmaceutical-Markets_R1537065 - Excerpt: Senior Analyst - Pharmaceutical Markets Madrid, Spain posted: Posted 30+ Days Ago ### Postdoctoral Fellowship-Immunology - Tonix Pharmaceuticals Holding Corp - Location: Frederick, MD 21701 (unspecified) - Salary: $75K-$95K - Posted: 2026-05-18 - 401(k) match: listed (not source-backed) - Apply: https://job-boards.greenhouse.io/tonixpharmaceuticals/jobs/4245264009 - Excerpt: Postdoctoral Fellowship-Immunology Frederick, MD 21701 Tonix Pharmaceuticals* is a fully integrated, commercial-stage biotechnology company focused on central nervous system (CNS) and immunology treatments in areas of high unmet medical need. TONMYA® (cyclobenzaprine HCl sublingual tablets 2.8 mg) is the first new treatment for fibromyalgia in adults in more than 15 years. Tonix's CNS commercial infrastructure supports its marketed products, including its acute migraine products, Zembrace® Symtouch® (sumatriptan injection 3 mg) and Tosymra® (sumatriptan nasal spray 10 mg). Tonix is investigating TONMYA® in Phase 2 clinical trials to evaluate its potential in major depressive disorder and acute stress disorder/acute stress reaction. Tonix is also advancing a pipeline of immunology programs, including TNX-4800, a Phase 2 ready long-acting human anti- Borrelia OspA monoclonal antibody (mAb) for the prevention of Lyme disease in the U.S., and TNX-1500, a Phase 2 ready third-generation CD40 ligand inhibitor for the prevention of kidney transplant rejection. In addition, the Company is progressing TNX-2900 (intranasal potentiated oxytocin), which is Phase 2 ready for the treatment of Prader-Willi syndrome, a rare disease. To learn more, visit www.tonixpharma.com and follow the Company on LinkedIn and X . *Tonix's product development candidates are investigational new drugs or biologics; their efficacy and safety have not been established and have not been approved for any indication. Zembrace SymTouch and Tosymra are registered trademarks of Tonix Medicines. TONMYA is a registered trademark of Tonix Pharma Limited. All other marks are property of their respective owners. Position Overview Tonix is seeking a highly motivated and ### Pharmaceutical Cleaner - AstraZeneca - Location: Australia – New South Wales (unspecified) - Salary: Not disclosed - Posted: 2026-06-03 - 401(k) match: listed (not source-backed) - Apply: https://astrazeneca.wd3.myworkdayjobs.com/Careers/job/Australia--New-South-Wales/Pharmaceutical-Cleaner_R-251307 - Excerpt: Pharmaceutical Cleaner Australia – New South Wales posted: Posted 9 Days Ago ### Pharmaceutical representative - The Procter & Gamble Company - Location: BUDAPEST GO - LIBERTY (unspecified) - Salary: Not disclosed - Posted: 2026-05-19 - Parental leave: 8 weeks (not source-backed) - Non-birth-parent leave: 8 weeks (not source-backed) - 401(k) match: listed (not source-backed) - Apply: https://pg.wd5.myworkdayjobs.com/1000/job/BUDAPEST-GO---LIBERTY/Pharmaceutical-representative_R000151450 - Excerpt: Pharmaceutical representative BUDAPEST GO - LIBERTY posted: Posted 24 Days Ago ### Senior Manager, Business Development – Pharma & Life Sciences - Axle - Location: Tysons, VA (unspecified) - Salary: $120K-$150K - Posted: 2026-02-03 - 401(k) match: listed (not source-backed) - Apply: https://job-boards.greenhouse.io/axle/jobs/5033813007 - Excerpt: Senior Manager, Business Development – Pharma & Life Sciences Tysons, VA (ID: 2026-1517) Axle Informatics is a bioscience and information technology company that offers advancements in translational research, biomedical informatics, and data science applications to research centers and healthcare organizations around the globe. With experts in biomedical science, software engineering, and program management, we focus on developing and applying research tools and techniques to empower decision-making and accelerate research discoveries. We work with premier research organizations and facilities including multiple institutes at the National Institutes of Health (NIH) and other public and private organizations. Benefits We Offer: - 100% Medical, Dental & Vision Coverage for Employees - Educational Benefits for Career Growth - Paid Time Off (Including Holidays) - Employee Referral Bonus - 401K Matching - Flexible Spending Accounts: - Healthcare (FSA) - Parking Reimbursement Account (PRK) - Dependent Care Assistant Program (DCAP) - Transportation Reimbursement Account (TRN) Position Summary Axle is seeking a driven and execution-focused Sales Leader to lead commercial growth across the Pharmaceutical and Biotechnology sectors. This role is designed for a self-directed builder who can independently identify opportunities, develop strategic relationships, and convert Axle's data, analytics, and technology capabilities into high-impact commercial engagements. T he right candidate will enter the role with an existing network and active book of business, and will be able to convert those relationships into revenue. This individual will serve as the primary commercial owner for pharma and life science companies, acting as a trusted advisor to pharmace utical manufacturers, CRO's, medical ### Assoc Director/Director, Pharmaceutical Development - Erasca Inc - Location: South San Francisco, CA (unspecified) - Salary: $200K-$225K - Posted: 2026-06-11 - 401(k) match: listed (not source-backed) - Mental health support: yes (not source-backed) - Apply: https://job-boards.greenhouse.io/erasca/jobs/7769033003 - Excerpt: Assoc Director/Director, Pharmaceutical Development South San Francisco, CA Erasca is a clinical-stage precision oncology company focused on discovering, developing and commercializing medicines for the benefit of patients with cancer. Our programs take novel approaches to shutting down one of cancer's most commonly mutated signaling cascades, the RAS/MAPK pathway, which affects approximately 5.5 million lives each year worldwide. The name “Erasca” has an important embedded meaning: it is a contraction of our audacious hope to “erase cancer” that drives our mission and everything that we do on behalf of patients with cancer. Position Summary: Reporting to the Sr Director Pharmaceutical Development, the Associate Director or Director of Pharmaceutical Development will be a liaison for the manufacture of Erasca's small molecule development drug products (DPs) at external contract development and manufacturing organizations (CDMOs). This individual will work on cross functional teams with colleagues from process development, analytical, formulation development, supply chain, QA, and regulatory CMC to plan, coordinate, and execute internal and external DP development and manufacturing activities. Essential Duties and Responsibilities: - Provide scientific, technical, and strategic direction to the design, development, and manufacture of investigational drug products from pre-clinical/clinical to commercial stage. - Manage activities and contractual relationship with contract manufacturers and laboratories performing product/formulation development, manufacturing, analytical development and testing, stability, and validation services. - Lead and collaborate with cross functional project team members to meet CMC goals. - Represent CMC DP and provide strategic recommendations and status reporting to cross-functional program team. - Author, review, and/or approve development ### Director, Health Economics & Outcomes Research (HEOR) - Vaxcyte Inc - Location: San Carlos, California, United States (unspecified) - Salary: $242K-$282K - Posted: 2026-03-09 - 401(k) match: listed (not source-backed) - Apply: https://boards.greenhouse.io/vaxcyte/jobs/5147570008?gh_jid=5147570008 - Excerpt: Director, Health Economics & Outcomes Research (HEOR) San Carlos, California, United States Join our Mission to Protect Humankind! Vaxcyte is a clinical-stage vaccine innovation company engineering high-fidelity vaccines to protect humankind from the consequences of bacterial diseases, which have serious and costly health consequences when left unchecked. Working to eradicate or treat bacterial infections such as invasive pneumococcal disease, Group A Strep, and Shigella is just the beginning. Our path to success is clear and well-defined, and Vaxcyte is set up to go the distance. WHAT we do is every bit as important as HOW we do it! Our work together is guided by four enduring core values: *RETHINK CONVENTION: We bring creative and intellectual diversity to every facet of the work we do in order to innovate and re-innovate the way vaccines are delivered. *AIM HIGH: We embody our collectively audacious goal to courageously make the most complex biologics ever attempted to protect humankind. *LEAD WITH HEART: Everyone leads at Vaxcyte with a kindness-first, inclusive approach to collaboration and vigorous debate that advances our business objectives. *MODEL EXCELLENCE: The magnitude of our challenge requires our shared commitment to demonstrating integrity, accountability, equality and clarity across communications and decision making. Summary: Vaxcyte is seeking a Director, Health Economics & Outcomes Research (HEOR) to establish and lead the company's health economic strategy across the vaccine lifecycle, with initial focus on adult pneumococcal programs. This strategic leadership role will be responsible for developing and executing global health economic models to support payer ### Associate Director, Clinical Quality Assurance - Revolution Medicines - Location: Redwood City, California, United States (unspecified) - Salary: $186K-$233K - Posted: 2026-05-05 - 401(k) match: listed (not source-backed) - Apply: https://www.revmed.com/careers-list/?gh_jid=7722995003 - Excerpt: Associate Director, Clinical Quality Assurance Redwood City, California, United States Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company's R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company's RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. As a new member of the Revolution Medicines team, you will join other outstanding professionals in a tireless commitment to patients with cancers harboring mutations in the RAS signaling pathway. The Opportunity: Revolution Medicines is seeking an Associate Director, Clinical Quality Assurance, who will play a key role within Quality Assurance and is responsible for providing leadership and compliance support for RevMed sponsored clinical trials with respect to RevMed's Standard Operating Procedures, applicable regulatory requirements (FDA, EU, ICH & country-specific), and current industry standards and practices. - Support the development and maintenance of applicable Quality Systems and procedures that comply with applicable GCP standards and guidelines. - Collaborate with clinical functions (e.g., Clinical Operations, Clinical Development) to provide GCP compliance support. - Participate in clinical study execution teams (CSETs) to enable risk-based quality management and a culture of quality and open dialogue. - Perform quality review of clinical trial documents with a focus on compliance / regulatory requirements and risk management. - Collaborate with internal stakeholders, external auditors, and auditees to support the planning, ### SVP, Pharmaceutical Sciences - Biocryst Pharmaceuticals INC - Location: US_North Carolina_Remote (unspecified) - Salary: Not disclosed - Posted: 2026-05-16 - 401(k) match: listed (not source-backed) - Apply: https://biocryst.wd501.myworkdayjobs.com/External/job/US_North-Carolina_Remote/SVP--Pharmaceutical-Sciences_JR100135-1 - Excerpt: SVP, Pharmaceutical Sciences US_North Carolina_Remote COMPANY: At BioCryst, we share a deep commitment to improving the lives of people living with hereditary angioedema (HAE) and other rare diseases. We leverage our expertise in structure-guided drug design to develop first-in-class or best-in-class oral small-molecule and injectable protein therapeutics, led by the efforts of our team of expert scientists in our Discovery Center of Excellence in Birmingham, Alabama. Our global headquarters is in Durham, North Carolina and our employees span the globe across sites in multiple countries. We are proud of our culture of engagement and accountability that rewards people for innovative thinking and achievement of key objectives. For more information, please visit our website at www.biocryst.com or follow us on LinkedIn and Instagram. JOB SUMMARY: The SVP of Pharmaceutical Sciences (Pharm Sci) is responsible for PharmSci strategy and execution across both biologics and small molecules, including drug substance and drug product development, clinical supplies, scale-up and technology transfer, and analytical development. ESSENTIAL DUTIES & RESPONSIBILITIES: Align project priorities, coordinate PharmSci activities, project deliverables and resources between PharmSci and other Developmental functions in BioCryst Mentor and develop a high performing PharmSci leadership team that efficiently coordinates activities across different PharmSci functional areas. Maintain seamless collaboration with other functional areas of the organization to ensure project progress according to agreed timelines especially research and discovery. Work closely with Clinical, Quality, Regulatory, Technical Operations, Preclinical and Finance functions in the company in the development and execution of PharmSci plans to meet corporate objectives. Serve ### Executive Director, Clinical Supply Chain - Revolution Medicines - Location: Redwood City, California, United States (unspecified) - Salary: $265K-$331K - Posted: 2026-04-10 - 401(k) match: listed (not source-backed) - Apply: https://www.revmed.com/careers-list/?gh_jid=7695198003 - Excerpt: Executive Director, Clinical Supply Chain Redwood City, California, United States Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company's R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company's RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. As a new member of the Revolution Medicines team, you will join other outstanding professionals in a tireless commitment to patients with cancers harboring mutations in the RAS signaling pathway. The Opportunity: The Executive Director, Clinical Supply Chain provides strategic leadership and operational oversight for end-to-end clinical supply chain activities across the organization. Strategic Leadership - Define and execute the global clinical supply chain strategy aligned with the company's clinical development pipeline and long-term business goals. - Establishes strategies and processes to ensure uninterrupted supply for Revolution Medicines portfolio across all phases of development. - Lead and serve as subject matter expert for clinical supply chain planning, risk management, and execution of clinical supply chain activities. - Build scalable processes and infrastructure to support early- through late-phase clinical programs. - Strategic Planning on comparator sourcing management to ensure timely, compliant and cost-effective product availability. - Effective management of clinical studies executed in conjunction with collaboration partners. - Identify and implement overall clinical supply chain best practices. Clinical Supply Operations - Oversee end-to-end clinical supply ### Senior Manager, Packaging and Serialization - Acadia Pharmaceuticals Inc - Location: Princeton, New Jersey, United States; San Diego, California, United States (unspecified) - Salary: $129K-$161K - Posted: 2026-03-03 - 401(k) match: listed (not source-backed) - Mental health support: yes (not source-backed) - Learning budget: yes (not source-backed) - Apply: https://acadia.com/en-us/careers/job-board/8438214002?gh_jid=8438214002 - Excerpt: Senior Manager, Packaging and Serialization Princeton, New Jersey, United States; San Diego, California, United States About Acadia Pharmaceuticals Acadia is committed to turning scientific promise into meaningful innovation that makes the difference for underserved neurological and rare disease communities around the world. Our commercial portfolio includes the first and only FDA-approved treatments for Parkinson's disease psychosis and Rett syndrome. We are developing the next wave of therapeutic advancements with a robust and diverse pipeline that includes mid- to late-stage programs in Alzheimer's disease psychosis and Lewy body dementia psychosis, along with earlier-stage programs that address other underserved patient needs. At Acadia, we're here to be their difference. Seeking talent near: Princeton, NJ; San Diego, CA Position Summary: Responsible for coordination of packaging (package design), artwork, and serialization with commercial Drug Product Contract Manufacturing organizations (CMO's), and other third party suppliers for products as identified. Subject matter expert in the field of serialization to oversee our CMOs running commercial and Acadia data management and integration. Experienced in the technical aspects of product introduction into the EU and other global markets as related to serialization, package design, and local requirements. Primary Responsibilities: - Develops and maintains good working relationships with both internal stakeholders and contract manufacturers. - Acquires and maintains scientific and technological knowledge and background of existing and new pharmaceutical (surface) serialization technologies to ensure our CMOs are aligned. Verifies CMO serialization technologies and ensures compliance with pharmaceutical regulatory requirements (EU FMD and DSCSA). - Coordinate periodic CMO Manufacturing meetings preparing ### Medical Director - Revolution Medicines - Location: Redwood City, California, United States (unspecified) - Salary: $295K-$339K - Posted: 2026-04-10 - 401(k) match: listed (not source-backed) - Apply: https://www.revmed.com/careers-list/?gh_jid=7695371003 - Excerpt: Medical Director Redwood City, California, United States Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company's R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company's RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. As a new member of the Revolution Medicines team, you will join other outstanding professionals in a tireless commitment to patients with cancers harboring mutations in the RAS signaling pathway. The Opportunity: We are seeking an experienced clinical science drug developer to serve as Medical Director in support of Revolution Medicines' clinical-stage molecule(s). In this critical role, you will support various clinical science deliverables and enable effective and efficient execution of the clinical development plan for a molecule(s) within its particular indication(s). The physician-scientist will focus on ensuring the accuracy, completeness, and integrity of clinical data supporting regulatory submissions (NDA, BLA, MAA). This role is uniquely positioned at the interface of clinical development, regulatory science, clinical data, and clinical operations, and will be instrumental in preparing pivotal datasets from the pivotal and supportive studies for successful global filings. The ideal candidate brings a strong foundation in clinical medicine (M.D. or equivalent), oncology experience, and proven expertise in clinical trial data review, cleaning, and regulatory submission preparation. The scope of data review and support activities spans early-stage clinical ### Technology, AI and Automation Intern, Europe - Acadia Pharmaceuticals Inc - Location: Zug, Switzerland (unspecified) - Salary: Not disclosed - Posted: 2026-02-27 - 401(k) match: listed (not source-backed) - Mental health support: yes (not source-backed) - Learning budget: yes (not source-backed) - Apply: https://acadia.com/en-us/careers/job-board/8442634002?gh_jid=8442634002 - Excerpt: Technology, AI and Automation Intern, Europe Zug, Switzerland About Acadia Pharmaceuticals Acadia is committed to turning scientific promise into meaningful innovation that makes the difference for underserved neurological and rare disease communities around the world. Our commercial portfolio includes the first and only FDA-approved treatments for Parkinson's disease psychosis and Rett syndrome. We are developing the next wave of therapeutic advancements with a robust and diverse pipeline that includes mid- to late-stage programs in Alzheimer's disease psychosis and Lewy body dementia psychosis, along with earlier-stage programs that address other underserved patient needs. At Acadia, we're here to be their difference. The Technology, AI & Automation Intern will support Acadia Europe by contributing hands-on technical expertise to identify, prototype, and deliver technology-enabled improvements across the European organization. This internship is planned for a duration of 2-4 months and is intended to provide targeted, project-based support outside of the standard intern program framework. The role is designed to bring current external perspectives on AI and automation into Acadia Europe, while enabling the intern to gain structured exposure to the pharmaceutical business. The intern will contribute cross-functionally to understanding business processes and deliver tangible, value-adding outputs aligned with Acadia's ways of working and compliance requirements. The position is paid and based in Baar (ZG), Switzerland. We are only able to consider students enrolled at Swiss learning institutions with valid work/stay permits. This internship provides hands-on exposure to applying AI and automation in a real-world pharmaceutical setting. The intern will gain insight into cross-functional ### Senior Manager, Cost Accounting - Tonix Pharmaceuticals Holding Corp - Location: Berkeley Heights, NJ or Frederick, MD or North Dartmouth, MA (unspecified) - Salary: $100K-$150K - Posted: 2026-05-21 - 401(k) match: listed (not source-backed) - Apply: https://job-boards.greenhouse.io/tonixpharmaceuticals/jobs/4248421009 - Excerpt: Senior Manager, Cost Accounting Berkeley Heights, NJ or Frederick, MD or North Dartmouth, MA Tonix Pharmaceuticals* is a fully integrated, commercial-stage biotechnology company focused on central nervous system (CNS) and immunology treatments in areas of high unmet medical need. TONMYA® (cyclobenzaprine HCl sublingual tablets 2.8 mg) is the first new treatment for fibromyalgia in adults in more than 15 years. Tonix's CNS commercial infrastructure supports its marketed products, including its acute migraine products, Zembrace® Symtouch® (sumatriptan injection 3 mg) and Tosymra® (sumatriptan nasal spray 10 mg). Tonix is investigating TONMYA® in Phase 2 clinical trials to evaluate its potential in major depressive disorder and acute stress disorder/acute stress reaction. Tonix is also advancing a pipeline of immunology programs, including TNX-4800, a Phase 2 ready long-acting human anti- Borrelia OspA monoclonal antibody (mAb) for the prevention of Lyme disease in the U.S., and TNX-1500, a Phase 2 ready third-generation CD40 ligand inhibitor for the prevention of kidney transplant rejection. In addition, the Company is progressing TNX-2900 (intranasal potentiated oxytocin), which is Phase 2 ready for the treatment of Prader-Willi syndrome, a rare disease. To learn more, visit www.tonixpharma.com and follow the Company on LinkedIn and X . *Tonix's product development candidates are investigational new drugs or biologics; their efficacy and safety have not been established and have not been approved for any indication. Zembrace SymTouch and Tosymra are registered trademarks of Tonix Medicines. TONMYA is a registered trademark of Tonix Pharma Limited. All other marks are property of their respective owners. ### Associate Director, Business Development - Acadia Pharmaceuticals Inc - Location: Princeton, New Jersey, United States; San Diego, California, United States (unspecified) - Salary: $158K-$198K - Posted: 2026-01-06 - 401(k) match: listed (not source-backed) - Mental health support: yes (not source-backed) - Learning budget: yes (not source-backed) - Apply: https://acadia.com/en-us/careers/job-board/8359293002?gh_jid=8359293002 - Excerpt: Associate Director, Business Development Princeton, New Jersey, United States; San Diego, California, United States About Acadia Pharmaceuticals Acadia is committed to turning scientific promise into meaningful innovation that makes the difference for underserved neurological and rare disease communities around the world. Our commercial portfolio includes the first and only FDA-approved treatments for Parkinson's disease psychosis and Rett syndrome. We are developing the next wave of therapeutic advancements with a robust and diverse pipeline that includes mid- to late-stage programs in Alzheimer's disease psychosis and Lewy body dementia psychosis, along with earlier-stage programs that address other underserved patient needs. At Acadia, we're here to be their difference. Seeking talent near: Princeton, NJ : San Diego, CA Position Summary: The Associate Director, Business Development will work collaboratively with a variety of company functions including External Innovation (Acadia's R&D Search and Evaluation team), Commercial, and Finance as well as external resources to review, landscape, identify and evaluate external assets to support and enhance the Acadia portfolio. We are seeking an individual with strong analytical and evaluation skills including data gathering and analysis, financial modeling experience and related analysis, competitive intelligence and scientific/commercial analysis of companies and programs in the pharmaceutical and biotech industry, as well as experience with BD transactions. The person in this role must have experience in identifying and analyzing the value of companies and programs within the pharmaceutical industry, building a business case for potential BD opportunities, and working with Executive management to implement corporate Business Development (BD) strategies. Primary ### Director, Medical Science Liaison (IL, IN) - Revolution Medicines - Location: Remote (United States) (remote) - Salary: $236K-$259K - Posted: 2026-05-14 - 401(k) match: listed (not source-backed) - Apply: https://www.revmed.com/careers-list/?gh_jid=7734099003 - Excerpt: Director, Medical Science Liaison (IL, IN) Remote (United States) Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company's R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company's RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. As a new member of the Revolution Medicines team, you will join other outstanding professionals in a tireless commitment to patients with cancers harboring mutations in the RAS signaling pathway. The Opportunity: We are seeking a highly motivated and experienced professional to join our team as a Lung Medical Science Liaison. Key aspects of this role will include engage in peer-to-peer scientific dialogue with healthcare professionals that translate into meaningful insights, serve as a therapeutic expert and thought partner to internal teams, liaison between Revolution Medicines and clinical study sites / investigators, and provide support for medical education, advisory boards, and medical congresses. Medical Science Liaisons (MSLs) are an essential member of the Medical Affairs team who will work as an extension of the Medical Affairs organization. The Lung MSL team will serve as a key liaison between Revolution Medicines and healthcare professionals. Within an assigned geographic territory, the MSL will be responsible for cultivating and strengthening professional relationships with key opinion leaders (KOLs), healthcare providers, and academic centers of excellence involved in various phases ### Graphic Designer – Pharmaceutical Marketing - Amgen - Location: India - Hyderabad (unspecified) - Salary: Not disclosed - Posted: 2026-05-12 - Parental leave: 6 weeks (not source-backed) - Non-birth-parent leave: 6 weeks (not source-backed) - 401(k) match: listed (not source-backed) - Apply: https://amgen.wd1.myworkdayjobs.com/Careers/job/India---Hyderabad/Graphic-Designer---Pharmaceutical-Marketing_R-240424 - Excerpt: Graphic Designer – Pharmaceutical Marketing India - Hyderabad posted: Posted 30+ Days Ago ### Pharmaceutical CIP/COP Technical Coordinator - Ecolab - Location: 3 Locations (unspecified) - Salary: Not disclosed - Posted: 2026-05-19 - Parental leave: 6 weeks (not source-backed) - Non-birth-parent leave: 6 weeks (not source-backed) - 401(k) match: listed (not source-backed) - Apply: https://ecolab.wd1.myworkdayjobs.com/Ecolab_External/job/DEU---Nordrhein-Westfalen---Monheim-am-Rhein/Pharmaceutical-CIP-COP-Technical-Coordinator_R00291546 - Excerpt: Pharmaceutical CIP/COP Technical Coordinator 3 Locations posted: Posted 24 Days Ago ### Senior Director, CMC Program Management - ORIC Pharmaceuticals - Location: South San Francisco, CA, United States (unspecified) - Salary: $275K-$310K - Posted: 2026-06-10 - Apply: https://jobs.smartrecruiters.com/ORICPharmaceuticals/3743990013359367-senior-director-cmc-program-management - Excerpt: Senior Director, CMC Program Management South San Francisco, CA, United States Company Description: ORIC Pharmaceuticals is a clinical stage biopharmaceutical company dedicated to improving patients' lives by Overcoming Resistance In Cancer. ORIC's clinical stage product candidates include (1) rinzimetostat (ORIC-944), an allosteric inhibitor of the polycomb repressive complex 2 (PRC2) via the EED subunit, being developed for prostate cancer, and (2) enozertinib, a brain penetrant inhibitor that selectively targets EGFR exon 20, HER2 exon 20 and EGFR atypical mutations, being developed across multiple genetically defined cancers. Beyond these two product candidates, ORIC® is also developing multiple precision medicines targeting other hallmark cancer resistance mechanisms. ORIC has offices in South San Francisco and San Diego, California. For more information, please go to www.oricpharma.com , and follow us on X or LinkedIn . This role requires a leader with strong business acumen to define and execute business processes that drive complex programs through global registration and commercialization. This role will play a pivotal part in bringing innovative therapies to patients by ensuring that CMC development, manufacturing, and commercialization are executed with excellence, speed, and financial discipline. This individual will also oversee project management including timelines, budgets, invoices, reports and documentation, and may assist with regulatory filings. This position reports to the Chief Technical Officer and is responsible for the following: Job Description: 1. End-to-End CMC Leadership & Cross-Functional Integration Create and execute against integrated cross-functional project plans, leading the integrated CMC strategy. Translate program strategy into cohesive development, manufacturing, and supply plans ### Manager, Quality Assurance, External Manufacturing - Vaxcyte Inc - Location: San Carlos, California, United States (unspecified) - Salary: $151K-$176K - Posted: 2026-04-29 - 401(k) match: listed (not source-backed) - Apply: https://boards.greenhouse.io/vaxcyte/jobs/5202025008?gh_jid=5202025008 - Excerpt: Manager, Quality Assurance, External Manufacturing San Carlos, California, United States Join our Mission to Protect Humankind! Vaxcyte is a clinical-stage vaccine innovation company engineering high-fidelity vaccines to protect humankind from the consequences of bacterial diseases, which have serious and costly health consequences when left unchecked. Working to eradicate or treat bacterial infections such as invasive pneumococcal disease, Group A Strep, and Shigella is just the beginning. Our path to success is clear and well-defined, and Vaxcyte is set up to go the distance. WHAT we do is every bit as important as HOW we do it! Our work together is guided by four enduring core values: *RETHINK CONVENTION: We bring creative and intellectual diversity to every facet of the work we do in order to innovate and re-innovate the way vaccines are delivered. *AIM HIGH: We embody our collectively audacious goal to courageously make the most complex biologics ever attempted to protect humankind. *LEAD WITH HEART: Everyone leads at Vaxcyte with a kindness-first, inclusive approach to collaboration and vigorous debate that advances our business objectives. *MODEL EXCELLENCE: The magnitude of our challenge requires our shared commitment to demonstrating integrity, accountability, equality and clarity across communications and decision making. Summary: The Manager, Quality Assurance, External Manufacturing is responsible for overseeing quality activities at contract manufacturing organizations (CMOs), ensuring compliance with cGMP standards, and driving performance through KPIs and continuous improvement initiatives. This role leads batch disposition, reviews critical GMP documentation, supports PPQ activities, and collaborates cross-functionally to resolve complex manufacturing and ### Principal Maintenance Specialist, Packaging - CVRM (Holly Springs) - Genentech, Inc. - Location: Los Angeles, California, United States of America (unspecified) - Salary: Not disclosed - Posted: 2026-03-19 - 401(k) match: listed (not source-backed) - Apply: https://roche.wd3.myworkdayjobs.com/ROG-A2O-GENE/job/California/Principal-Maintenance-Specialist--Packaging---CVRM--Holly-Springs-_202603-107074-1/apply - Excerpt: Principal Maintenance Specialist, Packaging - CVRM (Holly Springs) Los Angeles, California, United States of America We're seeking a highly skilled Maintenance Specialist with direct Pharmaceutical Packaging Equipment experience who will be accountable for leading troubleshooting and issue resolution for highly comp... ### Associate Director, Regulatory Affairs - Kalvista Pharmaceuticals INC - Location: Salisbury, UK (unspecified) - Salary: Not disclosed - Posted: 2026-04-23 - Apply: https://job-boards.greenhouse.io/kalvistapharmaceuticals/jobs/5198828008 - Excerpt: Associate Director, Regulatory Affairs Salisbury, UK About KalVista Pharmaceuticals, Inc. KalVista is a global pharmaceutical company dedicated to delivering life-changing oral therapies for individuals affected by rare diseases with significant unmet needs. The KalVista team discovered and developed EKTERLY®-the first and only oral on-demand treatment for hereditary angioedema (HAE)-and continues to work closely with the global HAE community to improve treatment and care for this disease around the world. For more information about KalVista, please visit www.kalvista.com and follow us on LinkedIn , X , Facebook and Instagram . ABOUT THE ROLE The Associate Director, Regulatory Affairs will join the Regulatory Development team at KalVista in contributing to the development of regulatory submissions in alignment with company objectives and support the successful commercialization of KalVista's products. The position provides regulatory expertise and guidance across both pre and post approval activities, serving as the regulatory lead for designated territories. Responsibilities include ensuring ongoing regulatory compliance within those territories while partnering cross-functionally to support strategic and operational regulatory requirements. RESPONSIBILITIES Support IND/NDA/MAA preparation, submissions, assessment and post approval activities in designated territories, in close collaboration with the Global Regulatory Lead Represent regulatory affairs in allocated launch teams as required Provide regulatory support to business development, commercial, market access, pharmacovigilance, supply chain and quality functions Working closely with other regulatory team members, to draft/put in place appropriate processes (SOPs) to ensure ongoing maintenance/regulatory compliance of marketing authorizations in designated markets Contribute to KalVista's Regulatory Intelligence process Maintain compliance with KalVista's Quality Management System ### Founder Associate - Mirelo AI - Location: Hybrid, Germany (hybrid) - Salary: Not disclosed - Posted: 2025-12-16 - Apply: https://jobs.ashbyhq.com/mirelo/11751713-b200-459d-8f2e-d153c811cd3d - Excerpt: Founder Associate Hybrid, Germany Mirelo AI is building the next generation of creative tools by generating realistic sound, speech and music from video. We develop cutting-edge foundational generative AI models that "unmute" silent video content and create custom, hyper-realistic audio for gaming, video platforms, and creators. Our technology empowers global storytellers to transform their content. We recently closed a $41 million Seed round co-led by Andreessen Horowitz and Index Ventures with participation from Atlantic, and are rapidly expanding across Product, Engineering, Go-to-Market, and Growth. About the Role As an early-stage startup, this role comes with exceptional breadth. While you'll work on highly strategic and intellectually challenging topics, you may also take on very practical, hands-on operational tasks to relieve the founders (e.g. coordination, logistics). We're therefore looking for someone ambitious, but also with a strong sense of ownership and a “nothing is below me” mindset. Key Responsibilities While your day-to-day will reflect the changing needs of the business, you'll generally focus on the following: - Support the CEO in allocating time to the highest-impact priorities while managing complex cross-functional scheduling and logistics that keep the team moving quickly. - Partner with the CEO to define team structure, support on hiring, and onboard new critical hires - Support in managing relationships with external stakeholders, including preparing for board meetings and investor updates - gathering data, crafting narratives, and designing presentation materials. - Support finance and administrative topics across the organization. - Jump into mission-critical, time-sensitive projects that require cross-functional coordination. - ### Director, Access Strategy Marketing NSCLC - Revolution Medicines - Location: Remote (United States) (remote) - Salary: $211K-$264K - Posted: 2026-04-17 - 401(k) match: listed (not source-backed) - Apply: https://www.revmed.com/careers-list/?gh_jid=7703635003 - Excerpt: Director, Access Strategy Marketing NSCLC Remote (United States) Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company's R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company's RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. As a new member of the Revolution Medicines team, you will join other outstanding professionals in a tireless commitment to patients with cancers harboring mutations in the RAS signaling pathway. The Opportunity: The Director, Access Strategy & Marketing will lead the development and execution of access strategy, value proposition development, and execution of marketing materials for the RevMed NSCLC portfolio (daraxonrasib, zoldonrasib and elironrasib). This role will focus on developing the short to medium term non-clinical value proposition across payers, HCPs, organized customers (GPOs, IDNs, etc) and channel partners. This role will be instrumental in supporting a successful launch through effective launch planning, tailored messaging to various customer types, and working cross-functionally with Market Access, Brand Marketing, Medical/HEOR, Regulatory and Compliance partners. The ideal candidate will also have experience in translating a dynamic policy and reimbursement landscape into access strategies over the product lifecycle (ie, impact of IRA, MFN, etc). This position is based out of our headquarters in Redwood City, CA. Remote candidates may be considered on case-by-case basis. Responsibilities may include: - Developing and ### Pharmaceutical Strategic Account Manager - Becton Dickinson - Location: 2 Locations (unspecified) - Salary: Not disclosed - Posted: 2026-06-08 - 401(k) match: listed (not source-backed) - Apply: https://bdx.wd1.myworkdayjobs.com/EXTERNAL_CAREER_SITE_USA/job/USA---Massachusetts---Boston/Pharmaceutical-Strategic-Account-Manager_R-547506-1 - Excerpt: Pharmaceutical Strategic Account Manager 2 Locations posted: Posted 4 Days Ago ### Senior Director, Economic Modeling - Revolution Medicines - Location: Redwood City, California, United States (unspecified) - Salary: $244K-$305K - Posted: 2026-04-10 - 401(k) match: listed (not source-backed) - Apply: https://www.revmed.com/careers-list/?gh_jid=7695564003 - Excerpt: Senior Director, Economic Modeling Redwood City, California, United States Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company's R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company's RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. As a new member of the Revolution Medicines team, you will join other outstanding professionals in a tireless commitment to patients with cancers harboring mutations in the RAS signaling pathway. The Opportunity: The Senior Director of Economic Modeling is responsible for defining and executing the economic modeling strategy to produce high quality health economic models & modeling strategies across Rev Meds portfolio. This is an exceptional opportunity to contribute to the advancement of healthcare by providing evidence that can shape the future of patient care in Oncology. Key Strategic Responsibilities: - Lead the development of strategic and operational plans for health economic modeling within Global HEOR & RWE (e.g., early and submission cost-effectiveness / utility models, budget impact models, and country adaptations) while ensuring alignment with Integrated Evidence Plans and appropriate Global stakeholders. - Partner with Global HEOR & RWE Executive Directors on core health economic modeling plans to support HTA, payer, and other access stakeholder assessments, submissions, negotiations, including associated value/HTA deliverables and publications to meet business and access objectives. - Provide strategic, methodological ### Lead Director, Pharmaceutical Contracting - CVS Health Corporation - Location: 4 Locations (unspecified) - Salary: Not disclosed - Posted: 2026-06-10 - Parental leave: 4 weeks (not source-backed) - Non-birth-parent leave: 4 weeks (not source-backed) - 401(k) match: listed (not source-backed) - Apply: https://cvshealth.wd1.myworkdayjobs.com/CVS_Health_Careers/job/IL---Downers-Grove/Lead-Director--Pharmaceutical-Contracting_R0933942 - Excerpt: Lead Director, Pharmaceutical Contracting 4 Locations posted: Posted 2 Days Ago ### Director, Medical Science Liaison (ND, SD, NE, MO, IA, KS) - Revolution Medicines - Location: Remote (United States) (remote) - Salary: $236K-$259K - Posted: 2026-05-19 - 401(k) match: listed (not source-backed) - Apply: https://www.revmed.com/careers-list/?gh_jid=7739061003 - Excerpt: Director, Medical Science Liaison (ND, SD, NE, MO, IA, KS) Remote (United States) Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company's R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company's RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. As a new member of the Revolution Medicines team, you will join other outstanding professionals in a tireless commitment to patients with cancers harboring mutations in the RAS signaling pathway. The Opportunity: We are seeking a highly motivated and experienced professional to join our team as a Lung Medical Science Liaison. Key aspects of this role will include engage in peer-to-peer scientific dialogue with healthcare professionals that translate into meaningful insights, serve as a therapeutic expert and thought partner to internal teams, liaison between Revolution Medicines and clinical study sites / investigators, and provide support for medical education, advisory boards, and medical congresses. Medical Science Liaisons (MSLs) are an essential member of the Medical Affairs team who will work as an extension of the Medical Affairs organization. The Lung MSL team will serve as a key liaison between Revolution Medicines and healthcare professionals. Within an assigned geographic territory, the MSL will be responsible for cultivating and strengthening professional relationships with key opinion leaders (KOLs), healthcare providers, and academic centers of excellence ### Pharmaceutical Internship - Pharmaziepraktikum* (f/m/d) - The Procter & Gamble Company - Location: Schwalbach Am Taunus (unspecified) - Salary: Not disclosed - Posted: 2026-05-18 - Parental leave: 8 weeks (not source-backed) - Non-birth-parent leave: 8 weeks (not source-backed) - 401(k) match: listed (not source-backed) - Apply: https://pg.wd5.myworkdayjobs.com/1000/job/Schwalbach-Am-Taunus/Pharmaceutical-Internship----Pharmaziepraktikum---f-m-d-_R000151566 - Excerpt: Pharmaceutical Internship - Pharmaziepraktikum* (f/m/d) Schwalbach Am Taunus posted: Posted 25 Days Ago ### Senior Director, Pipeline & Product Communications - Revolution Medicines - Location: Redwood City, California, United States (unspecified) - Salary: $244K-$305K - Posted: 2026-04-10 - 401(k) match: listed (not source-backed) - Apply: https://www.revmed.com/careers-list/?gh_jid=7695609003 - Excerpt: Senior Director, Pipeline & Product Communications Redwood City, California, United States Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company's R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company's RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. As a new member of the Revolution Medicines team, you will join other outstanding professionals in a tireless commitment to patients with cancers harboring mutations in the RAS signaling pathway. The Opportunity: The Senior Director, Pipeline & Product Communications will lead the strategy, development, and execution of integrated communications across the company's pipeline and product candidate portfolio. This role is accountable for shaping how Revolution Medicines' pipeline and product narratives are understood by external stakeholders, including scientific and medical audiences, patients and advocates, media, and the broader healthcare ecosystem. Reporting to the Head of Communications, this leader will serve as a trusted strategic advisor to cross-functional partners across R&D, Medical Affairs, Regulatory, Commercial, Market Access, Patient Advocacy, Legal, and Investor Relations. The role requires deep expertise across the full product lifecycle, from early clinical development through regulatory milestones and launch readiness, and the ability to translate complex science into clear, differentiated, and credible narratives. This is a high-impact leadership role for a communications professional who thrives at the intersection of science, strategy, people ### Apprentice Chemical and Pharmaceutical Technologist 2026 - Biogen - Location: Solothurn, Switzerland (unspecified) - Salary: Not disclosed - Posted: 2026-05-12 - 401(k) match: listed (not source-backed) - Apply: https://biibhr.wd3.myworkdayjobs.com/external/job/Solothurn-Switzerland/Apprentice-Chemical-and-Pharmaceutical-Technologist-2026_REQ21851 - Excerpt: Apprentice Chemical and Pharmaceutical Technologist 2026 Solothurn, Switzerland posted: Posted 30+ Days Ago ### Senior Manager, Indirect Procurement - Clinical - Vaxcyte Inc - Location: San Carlos, California, United States (unspecified) - Salary: $159K-$186K - Posted: 2026-04-22 - 401(k) match: listed (not source-backed) - Apply: https://boards.greenhouse.io/vaxcyte/jobs/5195377008?gh_jid=5195377008 - Excerpt: Senior Manager, Indirect Procurement - Clinical San Carlos, California, United States Join our Mission to Protect Humankind! Vaxcyte is a clinical-stage vaccine innovation company engineering high-fidelity vaccines to protect humankind from the consequences of bacterial diseases, which have serious and costly health consequences when left unchecked. Working to eradicate or treat bacterial infections such as invasive pneumococcal disease, Group A Strep, and Shigella is just the beginning. Our path to success is clear and well-defined, and Vaxcyte is set up to go the distance. WHAT we do is every bit as important as HOW we do it! Our work together is guided by four enduring core values: *RETHINK CONVENTION: We bring creative and intellectual diversity to every facet of the work we do in order to innovate and re-innovate the way vaccines are delivered. *AIM HIGH: We embody our collectively audacious goal to courageously make the most complex biologics ever attempted to protect humankind. *LEAD WITH HEART: Everyone leads at Vaxcyte with a kindness-first, inclusive approach to collaboration and vigorous debate that advances our business objectives. *MODEL EXCELLENCE: The magnitude of our challenge requires our shared commitment to demonstrating integrity, accountability, equality and clarity across communications and decision making. Summary: This is an exciting opportunity to lead procurement support for clinical development programs, serving as a strategic business partner to the Clinical Operations Department, while maintaining the ability to flex across enterprise-wide procurement priorities as business needs evolve. This role sits within the centralized Procurement function in Finance and serves --- Source-backed benefit claims include source links; other benefit values are labeled separately.